D. BENJAMIN BORSON, M.A., J.D., Ph.D.

CURRICULUM VITAE

21 October 2020

 

DISCLAIMER

 

            The information contained in this Curriculum Vitae is for informational purposes only, and does not imply or guarantee that any future or current legal representation will produce similar results.

 

EXECUTIVE EXPERIENCE

 

Founder and President, Borson Law Group, PC, Intellectual Property Law Practice

Adjunct Professor of Law, Golden Gate University School of Law

Past Member, Patent Public Advisory Committee, USPTO

Past Board Member and Past Chair, Business Law Corporate Counsel Section,

Contra Costa   County Bar Association

Chair, Legislation Interest Group, IP Law Section, State Bar of California

Co-Chair, Hot Topics Subcommittee, AIPLA

Co-Chair, Patent Policy Subcommittee, AIPLA

Co-Chair, Patent Law Subcommittee on Patentability, AIPLA

President and Board Member, Contra Costa Performing Arts Society

Past President, current Vice President and Board Member, Amphion Music Club

Past Member, New Zealand Biotechnology Organization

Past member of the Executive Committee, Intellectual Property Law Section, State Bar of   California; member of IP and International Law Sections

Past Co-Chair, Council of State Bar Sections

Founder and Past President, BioScience Forum

Past Chair, Northern California Pharmaceutical Discussion Group

Past Principal Investigator, NIH Grant-Funded research program in basic biomedical         research

Past President, Buchanan Flying Club

Past President, Bay Flute Club

 

LEGAL EXPERIENCE

 

Intellectual Property.  Develop and implement business-focused U.S. and foreign IP strategies.  Advise clients regarding requirements of patentability, scientific and legal strategies for supporting patent applications, trade secrets, licensing and trademark applications.  Advise clients regarding domestic and international intellectual property implications of business decisions, licensing, contracting and litigation.

 

Scientific Consultation: Experimental design and implementation; evaluation of methods and results.  Medical therapy and therapeutic standards in physiology, pharmaceuticals, molecular diagnostics and genetic markers of disease.

Patent Drafting: Drafting and filing provisional and utility patent applications, PCT and non-PCT foreign patent applications. Drafting patents relating to therapeutics including antisense, immunology, analytical methods, pharmaceuticals, bioinformatics, chemicals, medical devices, medical and semiconductor polymers, manufacturing processes, methods of use, semiconductor processing equipment for polymer deposition and manufacture, organic and inorganic chemistry, superconductors, information technology and software, oncogenes, nucleic acids, oncogene products; methods of use: immunoassays, antisense and antibody therapy, diagnostic methods, mechanical inventions, consolidation of applications and claim drafting. 

 

Patent Prosecution:  Biotechnology, chemical, pharmaceutical, bioinformatics, software, medical device, immunological, mechanical, superconductivity and semiconductor patent prosecution: drafting amendments relating to cellular uptake, efficacy of antisense nucleotide therapeutics, bio-polymer chemistry, semiconductors, medical chemistry.  Preparation of Information Disclosure Statements.  Drafting declarations and petitions supporting patentability. Drafting Opposition documents for foreign prosecution.  Consultation with foreign associates. Over 140 patents issued

 

Legal Opinions: Research and preparation of legal opinions regarding joint ventures, non-infringement and invalidity; due diligence analysis of patent applications, patents and patent portfolios. 

 

Contracts and Licensing: Negotiate and draft purchase and resale agreements, confidentiality agreements, employee agreements, consulting agreements, technology transfer and licensing agreements.  Evaluation of technical and legal services and due diligence.  Over 50 Licenses and Agreements and 12 validity or non-infringement opinions prepared.

 

Trademarks: Drafting, prosecution, and maintenance of trademark and service mark applications and registrations in United States and in foreign countries.

                                   

Dispute Resolution: Legal research and analysis, preparing motions and memoranda of points and authorities, filing court documents, court appearances, mediation and arbitration; draft cease and desist letters.

 

Client Development: Develop life sciences and high-technology practice.  Meet with prospective clients, discuss intellectual property strategies and services, develop and implement intellectual property strategies.  Portfolio of current clients includes immunology, bioinformatics, oncology, superconductors, pharmaceuticals, diagnostics, phototherapy, molecular diagnostics and assay development. 

 

Public Service: Develop and present lectures on Legal, Business and Scientific matters for U.S. and foreign clients; provide and coordinate input to legislative and agency rule-making processes. Past member Patent Public Advisory Committee of the USPTO; past member of IP Section Delegation to Washington DC and the USPTO.  Organize Educational Symposia on Science, Technology and Law.  Member, American Intellectual Property Law Association Patent, International Law and Biotechnology Committees.  Co-Chair, AIPLA Patent Sub-Committee on Section 101, Co-Chair Patentability Subcommittee, Co-Chair, Patent Policy Subcommittee.  Past Chair and current member of the Board, Business Law Corporate Counsel Section, Contra Costa County Bar Association.

 

Training Associates and Staff  Supervise attorneys. staff and interns in drafting and prosecution of patent applications, trademarks and trade secrets world-wide, patentability and infringement opinions, firm practices and USPTO practices.

 

Community Service  Perform musical works for non-profit organizations; organize and develop programming for non-profit musical organizations.

 

REPRESENTATIVE CLIENTS

 

Company                                             Technology

 

Acacia Patent Acquisition, LLC             Biotechnology

ADC2 Technologies, LLC.                    Video Compression and Decompression; software

Advanced Microdevices                        Semiconductor Manufacturing and Chemistry

Advanced Technology & Materials, Inc. Chemistry, Nanotechnology, Advanced Materials and

                                                                        Semiconductor             Manufacturing

AIST-NT, Inc.                                      Atomic Force Microscopy

Alpha Golf, Inc.                                    Medical Devices, Systems Engineering and Therapeutics

Apollo Future Technology, Inc.             Trademarks

Array Bioscience Corporation                Chemistry, Nanotechnology and Instrumentation

Attend Systems LLC                             Data Center Equipment Management Systems

Biophysica, Inc.                                    Organic Chemistry and Pharmaceuticals

Canon USA, Inc.                                   Advanced Materials, Semiconductor Manufacturing and

                                                                        Tools Design

Cellular Technology Limited                 Biotechnology and Diagnostic Instrumentation

DNP Pharmaceuticals                            Biotechnology and Nucleic Acid Therapeutics

Fisher and Associates                            Medical Diagnosis and Treatment

Fitzsimmons & Associates                    Ergonomics

FzioMed Inc.                                        Biotechnology; Medical Devices

GNI Ltd.                                               Biotechnology and Bioinformatics

Immune Solutions Ltd.                          Vaccines

MSM Protein Technologies                   Immunology, Antibody Therapeutics

Neuren Pharmaceuticals Limited            Biotechnology, Chemistry and Pharmaceuticals

Otago Innovation Ltd.                           Molecular Biology, Pharmaceuticals

Pacific Edge Ltd.                                   Genetic Testing, Diagnostics, and Bioinformatics                                                              Bioinformatics

Perseis Ltd.                                           Antibody Therapeutics and Diagnostics

Photomed Technologies, Inc.                 Medical Devices and Therapeutics

Powell, M.                                            Chemotherapeutics

PrognosDx                                            Molecular Diagnosis and Prognosis

Quantum Polymer Corporation               Chemistry, Nanotechnology and Advanced Materials

Rossi, T.                                               Agriculture

RPK Pharmaceuticals, Inc.                    Trademarks

Salesforce.com                                     Information Technology

Simpson Strong-Tie Company               Construction

Suncrest, USA Inc.                                Hydroponic Agriculture

Tolmei, R.                                            Mechanical Engineering

True Light Technologies, Inc.                Audiovisual Software

University of California                         Peptide Therapeutics

 

 

EMPLOYMENT IN THE LAW

 

2014                            Member, Committee on Professional Responsibility and Conduct, State Bar of California.

 

2010-2015                   Adjunct Professor of Law, Golden Gate University School of Law

 

2009-2012                   Member, Patent Public Advisory Committee, United States Patent and Trademark Office

 

2006-                           Founder and President, Borson Law Group, PC

 

2004 -  2006                Of Counsel: Fliesler Meyer LLP

                                    (formerly Fliesler, Dubb, Meyer & Lovejoy LLP)

 

2003                            Of Counsel:  Fliesler, Dubb, Meyer & Lovejoy LLP

 

1997 - 2003                 Associate:  Fliesler, Dubb, Meyer & Lovejoy LLP:

 

1996 - 1997                 Law Offices of Leona L. Lauder: Biotechnology patent prosecution

 

1996                            Philip A. Dalton & Associates: Mechanical patent preparation

 

1994                            University of San Francisco Continuing Legal Education Program

                                    LecturerUses of DNA Technology in Forensic Sciences.

Polymerase chain reaction, restriction fragment length polymorphism, statistical analysis.

 

1993                            Flehr, Hohbach, Test, Albritton, & Herbert, San Francisco, California       Summer Associate:

 

Biotechnology patent prosecution: drafting amendments pertaining to nucleic acids and proteins; methods of use including antisense therapy, diagnostic methods including immunoassays.

Litigation support: legal research and drafting: joinder, infringement, licensing. Patent portfolio evaluation.  Gene therapy, nucleic acid delivery.

Scientific consultation protein synthesis, cellular uptake of therapeutic agents.

 

1987 - 1992                 University of California, San Francisco and Genentech, Inc., South San Francisco

Experimental design: implementation of scientific support for patent applications.  Biotechnology patent prosecution: drafting disclosure documents and patent applications, declarations, and amendments relating to Therapeutic Uses and Composition and Matter of Enkephalinase.

 

LEGAL CERTIFICATION

 

            State Bar of California

            United States District Court for the Northern District of California

            Registered to Practice before the U.S. Patent and Trademark Office

           

EDUCATION           

 

            University of San Francisco School of Law.   J.D., 1995

            University of California, San Francisco.   Ph.D. Physiology, 1983 

            University of California, Riverside.   M.A. Biology, 1973

            San Francisco State College.   B.A. Biology, 1969

 

PROFESSIONAL ORGANIZATIONS

 

BioScience Forum (Founder and Past President)

            Northern California Pharmaceutical Discussion Group (Past Chair)

            Past Member, Patent Public Advisory Committee (PPAC), USPTO (2009-2012)

            State Bar of California

                        Committee on Professional Responsibility and Conduct (COPRAC; 2013-

                                    2014)

                        Professional Liability Insurance Availability and Affordability Working

                                    Group

                        Council of Sections Advisor (2005-2006)

                        Council of Sections (Co-Chair 2004-2005)

                        Council of Sections (Co-Vice Chair 2003-2004)

                        Intellectual Property Section

                                    Legislation Interest Group (Chair 2006-)

                                    Council of State Bar Sections IP Representative (2004-2006)

                                    Executive Committee (2001-2004)

                                    Patent Standing Committee (1999- )

                                    Special Commission on Proposed USPTO Rules (Chair)

                        Board of Governor’s Task Force on Sections (Section Representative                       

                                    2004-2006)

                        IP Section Delegate, Conference of California Bar Associations (2007-

                                    2010)

Am. Intel. Prop. Law Assoc. Biotechnology, International law and Patent Committees,         

            Co-Chair, Hot Topics Subcommittee (2016- )

            Co-Chair, Patent Policy Subcommittee (2014-2016)

            Co-Chair, Patentability Subcommittee (2011-2014)

            Co-Chair, Patent Subcommittee on Section 101 (2009-2011).

           

            Contra Costa County Bar Association, Chair, Business Law Corporate Counsel

                        Section (2011-2013), Treasurer (2014-2016)

            Federal Circuit Bar Association (past)

            San Francisco Intel. Prop. Law Assoc. (past)

            Federated Association of Societies for Experimental Biology (past)

            American Lung Association (past)

            American Physiology Society (past)

            American Association of Cell Biologists (past)

            American Chemical Society (past)

            American Association of Pharmaceutical Scientists (past)

 

PROFESSIONAL DEVELOPMENT

            Originated and maintained legal practice relating to life sciences, chemistry, semiconductor manufacturing, copyright, IP counseling and IP transactions, in pharmaceuticals, analytical instrumentation, biotechnology, genetics, information technology, bioinformatics, immunology, diagnostics, therapeutics, superconductive materials and semiconductor processing.

 

 

PATENTS PREPARED, PROSECUTED AND/OR ISSUED

 

1.         Jui H. Wang et al., Poly-Substituted-Phenyl-Oligoribonucleotides Having Enhanced Stability and Membrane Permeability and Methods of Use, U.S. Pat. No: 5,858,988, issued Jan 12, 1999.

 

2.         Herbert E. Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing Surgical Adhesions. U.S. Pat. No: 5,906,997, issued May 25, 1999.

 

3.         Radu Barsan et al., Use of Borophosphorous Tetraethyl Orthosilicate (BPTEOS) to Improve Isolation in a Transistor Array.  U.S. Patent No: 5,908,308, issued June 1, 1999.

 

4.         James E. Currie et al., Planarization Composition for Removing Metal Films.  U.S. Pat. No: 5,993,685, issued November 30, 1999.

 

5.         Ashraf R. Khan et al., Surface Modification of Semiconductors Using Electromagnetic Radiation.  U.S. Pat. No: 6,015,759, issued January 18, 2000.

 

6.         Herbert E. Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing Surgical Adhesions.  U.S. Pat. No: 6,017,301, issued January 25, 2000.

 

7.         Chung J. Lee et al., Precursors for Making Low Dielectric Constant Materials with Improved Thermal Stability. U.S. Pat. No: 6,020,458, issued February 1, 2000.

 

8.         Herbert E. Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing Surgical Adhesions.  U.S. Pat. No: 6,034,140, issued March 7, 2000.

 

9.         Giovanni Antonio Foggiato et al., Large Area Discharge Excitation Radiator.  U.S. Pat. No: 6,049,086, issued April 11, 2000.

 

10.       Chung J. Lee et al., Low Dielectric Constant Materials and Method. U.S. Pat. No: 6,051,321, issued April 18, 2000.

 

11.       Sunil D. Mehta et al., Annealing of Silicon Oxynitride and Silicon Nitride Films to Eliminate High Temperature Charge Loss.  U.S. Pat. No: 6,071,784, issued June 6, 2000.

 

12.       David Leksell et al., Chamber for Reducing Contamination During Chemical Vapor Deposition..  U.S. Pat. No: 6,079,353, issued June 27, 2000.

 

13.       Chung J. Lee et al., Deposition Systems and Processes for Transport Polymerization and Chemical Vapor Deposition.  U.S. Pat. No: 6,086,679, issued July 11, 2000.

 

14.       Gouxi Pan, High Hardness and Wear-Resistant Flux Cored Wire.  U.S. Pat. No: 6,103,997, issued August 15, 2000.

 

15.       David Leksell et al., Chamber for Reducing Contamination During Chemical Vapor Deposition.  U.S. Pat. No: 6,114,227, issued September 5, 2000.     

 

16.       Herbert E. Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing Surgical Adhesions. U.S. Pat. No: 6,133,325, issued October 17, 2000.                         

 

17.       Chung J. Lee et al., Chemicals and Methods for Making Fluorinated Poly(Para-Xylylenes).  U.S. Pat. No: 6,140,456, issued October 31, 2000.

 

18.       Yue-Song He et al.,    Barrier Layer Decreases Nitrogen Contamination of Peripheral Gate Regions During Tunnel Oxide Nitridation.  U.S. Pat. No: 6,143,608, issued November 7, 2000.

 

19.       Zoran Krivokapic, Convex Device with Selectively Doped Channel.  U.S. Pat. No: 6,153,454, issued November 28, 2000.

     

20.       William Oppelt, et al., Laparoscopic Insertion and Deployment Device,  U.S. Pat. No: 6,193,731, issued February 27, 2001.

 

21.      Lu You et al., Cure Process for Manufacture of Low Dielectric Constant Interlevel Dielectric Layers.  U.S. Pat. No: 6,200,913, issued March 13, 2001.

 

22.       Jonathan Lin et al., Improving Field Leakage by Using a Thin Layer of Nitride Deposited by Chemical Vapor Deposition.  U.S. Pat. No: 6,211,022, issued April 3, 2001.

 

23.       Lu You et al., Rapid Acceleration Methods for Global Planarization of Spin-On Films.  U.S. Pat. No: 6,225,240, issued May 1, 2001.

 

24        Effiong Ibok,   Graded Anti-Reflective Barrier Films for Ultra-Fine Lithography

            U.S. Pat. No: 6,235,456, issued May 22, 2001.         

 

25.       Chung J. Lee et al., Precursors for Making Low Dielectric Constant Materials with Improved Thermal Stability.  U.S. Pat. No. 6,258,407 B1, issued July 10, 2001.

 

26.       James E. Currie et al., Planarization Compositions for Removing Metal Films.  U.S. Pat. No. 6,267,909, issued July 31, 2001.

 

27.       Jui H. Wang.  Antiviral Anticancer Poly-Substituted Phenyl Derivatized Oligoribonucleotides and Methods for Their Use.  U.S. Pat. No. 6,291,438, issued September 18, 2001.

 

28.       Hyeon-Seag Kim et al., Process for Manufacturing Shallow Trenches Filled With Dielectric Material Having Low Mechanical Stress.  U.S. Pat. No: 6,297,128, issued October 2, 2001.

 

29.       Seshu B. Desu et al., Near-Room Temperature Thermal Chemical Vapor Deposition of Oxide Films, U.S. Pat. No: 6,316,055, issued November 13, 2001.

 

30.       Lu You et al., Apparatus and Methods for Uniform Scan Dispensing of Spin on Materials.  U.S. Pat. No: 6,317,642, issued November 13, 2001.

 

31.       David Greenlaw et al., Process to Separate the Doping of Polygate and Source Drain Regions in Dual Gate Field Effect Transistors.  U.S. Pat. No: 6,319,804, issued November 20, 2001.

 

32.       Richard Brewer, Thomas J. Grebinski, James E. Currie, Michael Jones, William Muller, and Ann Nguyen, Planarization Compositions and methods for Removing Interlayer Dielectric Films, U.S. Patent No. 6,122,600, issued November 27, 2001.

 

33.       Chung J. Lee et al., Low Dielectric Constant Materials with Improved Thermal and Mechanical Properties.  U.S. Pat. No: 6,323,297, issued November 27, 2001.

 

34.       Seshu B. Desu et al., Oxide/Organic Polymer Multilayer Thin Films Deposited by Chemical Vapor Deposition. U.S. Pat. No: 6,358,863 B1, issued March 19, 2002.

 

35.       Lu You et al., Solution Flow-In for Uniform Deposition of Spin-on Films.

            U.S. Pat. No: 6,387,825, issued May 14, 2002.

 

36.       Lu You et al., Methods of Manufacture of Uniform Spin-On Films.  U.S. Pat. No: 6,407,009, issued June 18, 2002.

 

37.       Hyeon-Seag Kim, Gate Insulator Process for Nanometer Mosfets.  U.S. Pat.

            No: 6,413,826, issued July 2, 2002.

 

38.       Effiong Ibok, Method for Fabricating High Permitivity Dielectric Stacks Having Low Buffer Oxide.  U.S. Pat. No: 6,417,041, issued July 9, 2002.

 

39.       Heyon-Seag Kim et al., Process for Manufacturing Shallow Trenches Filled With Dielectric Material Having Low Mechanical Stress. U.S. Pat. No: 6,455,912, issued September 24, 2002.

 

40.       Desu et al., Near-Room Temperature CVD Synthesis of Organic Polymer/Oxide Dielectric Nanocomposites.  U.S. Patent No: 6,495,208 B1, issued December 17, 2002.

 

41.       Lu You et al., Closed Deposition Apparatus and Methods for Regulating Drying of Spin-On Films.  U.S. Pat. No: 6,530,340 B2, issued March 11, 2003.

 

42.       Chung J. Lee et al., Precursors for Making Low Dielectric Constant Materials With Improved Thermal Stability.  U.S. Pat. No: 6,534,616, issued March 18, 2003.

 

43.       Raisa V. Talroze and Leonid N. Grigorov, Conductive Polymer Materials and Methods for Their Manufacture and Use, U.S. Pat. No: 6,563,132, issued May 13, 2003.

 

44.       Mark E. Miller et al., Polyacid/Polyalkylene Oxide Foams and Gels and Methods for Their Delivery, U.S. Pat. No: 6,566,345 B2, issued May 20, 2003.

 

45.       Peter D. Gluckman et al., Regulation of Tyrosine Hydroxylase. U.S. Pat. No: 6,617,311 B1, issued September 9, 2003.

 

46.       Chung J. Lee et al., Low Dielectric Constant Materials Prepared From Photon or Plasma Assisted Chemical Vapor Deposition and Transport Polymerization of Selected Compounds.  U.S. Pat. No: 6,663,973, issued December 16, 2003.

 

47.       Tajrena Alexi, Methods for Promoting Weight Gain Using GPE-Related Compounds. U.S. Pat. No: 6,682,753 B2, issued January 27, 2004.

 

48.       David I. Kreimer et al., Systems and Methods for Filter Based Spectrographic Analysis.  U.S. Pat. No: 6,707,548, issued March 16, 2004.

 

49.       Milos Sovak et al., A Topical Antiandrogen for Hair Loss and Other Hyperandrogenic Conditions. European Patent No: 1 169 301.

 

50.       Peter Gluckman et al., Use of GPE to Protect Glial Cells or Non-Dopaminergic Cells From Death From Neural Injury of Disease. U.S. Pat. No: 6,780,848, issued August 24, 2004.

 

51.       Peter Gluckman et al., Methods to Improve Neural Outcome.  U.S. Pat. No: 6,812,208, issued November 2, 2004.

 

52.       Milos Sovak et al., Topical Antiandrogen for Hair Loss and Other Hyperandrogenic Conditions. U.S. Pat. No: 6,828,458, issued December 4, 2004.

 

53.       Raisa Talroze et al., Conductive Polymer Materials and Methods for their Manufacture and Use,  U.S. Pat. No: 6,844,567, issued January 18, 2005.

 

54.       Lance Hunter, Shaving Cream Dispenser.  U.S. Pat. No: 6,860,413, issued March 1, 2005.

55.       Herbert Schwartz et al., Compositions of Polyacids and Polyethers and Methods for Their Use in Reducing Adhesions.  U.S. Pat. No: 6,869,938, issued March 22, 2005.

 

56.       Allan Gardiner et al., Illuminator with Filter Array and Bandwidth Controller.  U.S. Pat. No: 6,886,964, issued May 3, 2005.

 

57.       Lin-Shu Lin et al., Chemically Activated Carboxypolysaccharides and Methods for Use to Inhibit Adhesion Formation and Promote Hemostasis.  U.S. Pat. No: 6,923,961, issued August 2, 2005.

 

58.       Christopher Williams, Processing EEG Signals to Predict Brain Damage.  U.S. Pat. 6,931,274, issued August 16, 2005.

 

59.       Mark Vickers et al., Treatment of Hypertension Using Growth Hormone in Mammals Subjected to Fetal Programming.  U.S. Pat. No: 6,933,278, issued August 23, 2005.

 

60.       Peter Gluckman et al., Regulation of Tyrosine Hydroxylase by GPE.  U.S. Pat. No: 6,933,282, issued August 23, 2005.

 

61.       Leonid Grigorov et al., Quantum Devices Based on Crystallized Electron Pairs and Methods for Their Manufacture and Use.  U.S. Pat. No: 7,014,795, issued March 21, 2006.

 

62.       Norman Abood et al., GPE Analogs and Peptidomimetics, U.S. Pat. No: 7,041,214, issued May 9, 2006.

 

63.       William Oppelt et al., Hemostatic Compositions of Polyacids and Polyalkylene Oxides and Methods for Their Use.  Australian Patent No: 2001255716.

 

64.       Peter Gluckman et al., GPE AnalogsU.S. Pat. No: 7,112,570, issued September 26, 2006.

 

65.       Chung Lee et al., Precursors for Making Low Dielectric Constant Materials With Improved Thermal Stability.  Korean Patent No: 602222, registered July 10, 2006.

 

66.       Chung Lee et al., New Deposition Systems and Processes for Transport Polymerization and Chemical Vapor Deposition.  Korean Patent No: 621226, registered August 30, 2006.

 

67.       Constance Haber et al., Therapeutic Methods Using Electromagnetic Radiation.  U.S. Pat. No: 7,150,710, issued December 19, 2006.

 

68.       Geoffrey Krissansen et al., Treatment of Demyelinating Diseases.  U.S. Pat. No: 7,192,931, issued March 20, 2007.

 

69.       Richard Berg et al., Compositions of Polyacids and Polyethers and Methods for Their Use as Dermal Fillers.  U.S. Pat. No: 7,192,984, issued March 20, 2007.

 

70.       Mark Miller et al., Polyacid/Polyalkylene Oxide Gels and Methods for Their Delivery, U.S. Pat. No; 7,265,098, issued September 4, 2007.

 

71.       David Batchelor et al., Methods for Detecting Weakly Immunogenic Analytes.  U.S. Pat. No: 7,282,432, issued October 16, 2007.

 

72.       Michael Powell, Diagnosis and Treatment of Human Dormancy Syndrome,  U.S. Pat. No: 7,288,257, issued October 30, 2007.

 

73.       Arjen Scheepens et al., Neuroprotective Effect of Growth Hormone.  U.S. Pat. No: 7,304,029, issued December 4, 2007.

 

74.       Angel DeCegama, Methods for Real-Time Software Video/Audio Compression, Transmission, Decompression and Display.  U.S. Pat. No: 7,317,840, issued January 8, 2008.

 

75.       Anthony Reeve et al., Medical Applications of Adaptive Learning Systems Using Gene Expression Data.  U.S. Pat. No: 7,370,021, issued May 6, 2008.

 

76.       Seiya Imoto et al., Biological Discovery Using Gene Regulatory Networks Generated from Multiple-Disruption Expression Libraries. U.S. Pat. No. 7,430,475, issued September 30, 2008.

 

77.       Michael Powell. Diagnosis and Treatment of Human Dormancy-Related Sequellae, U.S. Pat. No: 7,485,298, issued February 3, 2009.

 

78.       Paul William Richard Harris et al., Neuroprotective Macrocyclic Compounds and Methods for Their Use, U.S. Pat. No: 7,485,630, issued February 3, 2009.

 

79.       Ron Tolmei, Activation of Remote Control Transmitter Functions by External Inputs. U.S. Pat. No: 7,535,401, issued May 19, 2009.

 

80.       Norman A. Abood and Margaret Anne Brimble, GPE Analogs and Petpidomimetics, European Patent No: EP 1 401 808 B1, granted 8 July 2009.

 

81.       Frank Sieg, Edmund Hughes, Thorsten Gorba, Neural Regeneration Peptides and Methods for Their Use in Treatment of Brain Damage, U.S. Pat. No: 7,563,862, issued July 21, 2009.

 

82.       Paul V. Lehmann, Alexey Y. Karulin, and Thomas Oliver Kleen, Nanoparticle and Microparticle Based Detection of Cellular Products.  U.S. Pat. No: 7,598,093, issued October 6, 2009.

 

83.       Peter David Gluckman, Gregory Brian Thomas, Jian Guan, Michael Dragunov, Ashmit Kumar Anand, Frank Sieg, and Margaret Anne Brimble, Effects of Glyucyl-2 Methyl-Prolyl Glutamate on Neurodegeneration.  U.S. Pat. No: 7,605,177, issued October 20, 2009.

 

84.       Frank Sieg, Edmund Hughes, Thorsten Gorba, Neural Regeneration Peptides and Methods for Their Use in Treatment of Brain Damage, Japanese Patent No: 4,399,260, issued October 30, 2009.

 

85.       Frank Sieg et al. Neural Regeneration Peptides and Methods for Their Use in Treatment of Brain Damage.  Japanese Patent No. 4,399,260, issued January 13, 2010.

 

86.       Michael Powell, Diagnosis and Treatment of Human Dormancy Syndrome, U.S. Pat. No: 7, 648,704, issued January 19, 2010.

 

87.       Ron Tolmei, Means, Methods, and Apparatus to Reduce the Possibility of a Motor Vehicle Entering a Freeway Ramp in the Wrong Direction of Travel, Towards Oncoming Traffic,. U.S. Pat. No:  7,650,236, issued January 19, 2010.

 

88.       Peter David Gluckman, Margaret Anne Brimble, Douglas Wilson, Frank Casper Tortella, Anthony Joseph Williams, Xi-Chun May, Jed. A. Hartings and Devina Gryder, Treatment of Non-Convulsive Seizures in Brain Injury Using G-2-Metheyl-Prolyl-Glutamate, U.S. Pat. No: 7,714,020, issued May 11, 2010.

 

89.       Allan Gardiner and Brent Michael McCullough, Systems and Methods for Displaying Changes in Biological Reponses to Therapy, U.S. Pat. No: 7,720,306, issued May 18, 2010.

 

90.       Frank Ernest Aldwell, Bryce Malcolm Buddle, and Ian George Tucker, Antigenic Compositions, U.S. Pat. No: 7,758,869, issued July 20, 2010.

 

91.       Frank Sieg et al. Neural Regeneration Peptides and Methods for Their Use in Treatment of Brain Damage.  U.S. Pat. No. 7,776,786, issued August 3, 2010.

 

92.       Au-Yeung Kwok-Leung and Lee B. Bussey. Apparatus and Methods for Preparative Scale Purification of Nucleic Acids, U.S. Pat. No. 7,771,945, issued August 10, 2010.

 

93.       Margaret Anne Brimble and Jian Guan, Cyclic G-2AllylProline in Treatment of Parkinson’s Disease, U.S.. Pat. No. 7,776,876, issued August 17, 2010.

94.       Robert Bridenbaugh, Warren Dang, and Lee B. Bussey, Methods for Purifying Nucleic Acids.  U.S. Pat. No. 7,807,822, issued October 5, 2010.

 

95.       Margaret Anne Brimble, Paul William Harris, and Frank Sieg, Analogs of Glycyl-Prolyl-Glutamate, U.S. Pat. No. 7,863,304, issued January 4, 2011.

 

96.       Constance Haber and Allan Gardiner, Therapeutic Methods Using Electromagnetic Radiation, U.S. Pat. No. 7,878,965, issued February 1, 2011.

 

97.       Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral Formulations of Glycyl-2-Methyl Prolyl Glutamate, U.S. Pat. No. 7,887,839, issued February 15, 2011.

 

98.       Constance Haber and Allan Gardiner, Therapeutic Methods Using Electromagnetic Radiation, U.S. Pat. No. 7,918,779, issued April 5, 2011.

 

99.       Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, Johan Lindsay McCall, Yu-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer, Singapore Patent No. 143,707, granted 29 April 2011.

 

100.     Ron Tolmei, Visual Indicator for Electrosurgical Instrument Fields, U.S. Pat. No. 7,963,957, issued June 21, 2011.

 

101.     Paul William Richard Harris and Margaret Anne Brimble, Neuroprotective Macrocyclic Compounds and Methods for Their Use, U.S. Pat. No. 8,013,170, Issued September 6, 2011.

 

102.     Frank Ernest Aldwell, Bryce Malcolm Buddle and Ian George Tucker, Antigenic Compositions, Chinese Patent No. ZL 02817408.9, Issued 7 September 2011.

 

103.     Angel DeCegama, Systems and Methods for Compression,Transmission and Decompression of Video Codecs, U.S. Pat. No. 8,031,782, issued October 4, 2011.

 

104.     Margaret Anne Brimble et al., Neuroprotective Bicyclic Compounds and Methods for Their Use, Japanese Patent No. 4842817, granted 14 October 2011.

 

105.     Margaret Brimble, Jian Guan, Frank Sieg, Neuroprotective Bicyclic Compounds and Methods for Their Use, U.S. Pat. No.8,067,425, issued November 29, 2011.

 

106.     Michael Powell.  Diagnosis and Treatment of Cancer Related to Human Dormancy, U.S. Pat. No. 8.075,902, issued December 13, 2011.

 

107.     Ron Tolmei. Centre High Mount Stop Lamp with Constituent Seatbelt Disengagement Indicator, U.S. Pat. No. 8.081,068, issued December 20, 2011.

 

108.     Paul V. Lehmann, Alexey V. Karulin, and Thomas Oliver Kleen, Nanoparticle and Microparticle Based Detection of Cellular Products, U.S. Pat. No. 8,088,630, issued January 3, 2012.

 

109.     Tim Zapalski, Apparatus and Method for Generating and Tracing Vortices, U.S. Pat. No. 8,146,893, issued April 3, 2012.

 

110.     Kwok-Leung Au-Yeung and Lee Bussey, Apparatus and Method for Preparative Scale Purification of Nucleic Acids, U.S. Pat. No. 8,158, 348, Issued April 17, 2012.

 

111.     Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral Formulations of Glycyl-2-Methyl Prolyl Glutamate, U.S. Pat. No. 8,178,125, issued May 15, 2012.

 

112.     Samuel Nochumson, Ross Durland, Audrey Yu-Speight, John Welp, Kouwei Wu, and Rexford Hayes, Process and Equipment for Plasmid Purification, U.S. Pat. No. 8,236,495, issued August 7, 2012.

 

113.     Noah Groth, Jan P. Warhuus, and Krassimir Anastassov Boyadjiev, Data Center Equipment Locator and Monitoring System, U.S. Pat. No. 8,264,354, issued September 11, 2012.

 

114.     Quentin Lewis Hibben, Low Temperature Curable Adhesive Compositions, U.S. Pat. No. 8,334,346, Issued December 18, 2012.

 

115.     Allan Gardiner and Tai Huynh, Therapeutic Methods Using Electromagnetic Radiation, U.S. Pat. No. 8,343,026, Issued January 1, 2013.

 

116.     Michael Powell, Diagnosis and Treatment of Human Dormancy Related Sequellae, U.S. Pat. No. 8,343,485, Issued January 1, 2013.

 

117.     Leonid Grigorov, Methods and Devices for Programmable Delivery of Microdoses of Liquid Drugs and Other Fluids, U.S. Pat No. 8,435,212, Issued May 7, 2013.

 

118.     Frank Aldwell, Bryce Malcolm Buddle, and Ian George Tucker, Antigenic Compositions.  Canadian Patent No. 2,454,920, Granted 25 June 2013.

 

119.     Jingyuan Wen, Gregory Brian Thomas, and Mike John Bickerdike, Oral Formulations of Glycyl-2-Methylprolyl-Glutamate, U.S. Patent No. 8,496,963, Issued July 30, 2013.

120.     Angel DeCegama, Systems and Methods for Compression, Transmission and Decompression of Video Codecs, U.S. Patent No. 8,503,543, Issued August 6, 2013.

 

121.     Joseph A. Mendoza, Remote Key Device, U.S. Patent No. 8,511,122, Issued August 20, 2013.

 

122.     Mike John Bickerdike, Margaret Anne Brimble, and Ernest Stephen Siritmanne, Cyclic-Glycyl-2-Allyl Proline and Its Use in Treatment of Peripheral Neuropathy, U.S. Patent No. 8,519,127, issued August 27, 2013

 

123.     Ashraf R. Khan, Sasangan Ramanathan, and Giovanni Antonio Foggiato, Surface Modification of Semiconductors Using Electromagnetic Radiation, European Patent No. 1,038,307, granted 11 September 2013.

 

124.     Peter David Gluckman, Jian Guan, Mary-Anne Woodnorth, and Margaret Anne Brimble, Method for Cognitive Enhancement and Cognitive Therapy Using Glycyl-2-Methyl Prolyl Glutamate.  U.S. Patent No. 8,637, 567, issued January 28, 2014.

 

125.     Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann, Robert Rosenberg, Anthony Edjund Reeve, Michael Alan Black, John Lindsay McCall, Yu-Hsiu Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer, Hong Kong Patent No. HK1127125, granted 28 February 2014.

 

126.     Robert Bridenbaugh, Warren Dang, and Lee Bussey, Methods for Purifying Nucleic Acids, U.S. Patent No. 8,680,261, issued March 25, 2014.

 

127.     Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral Formulations of Glycyl-2-Methylprolyl-Glutamate, European Patent No. EP 2 001 400 B1, granted 7 May 2014.

 

128.     Noah Groth, Jan P. Warhuus, and Krassimir Anastassov Boyadjiev, Data Center Server Location and Monitoring System,  U.S. Patent No. 8,779,922, issued July 15, 2014.

 

129.     Michael John  Bickerdike and Jian Guan, Cyclic Glycyl-2-AllylProline Improves Cognitive Performance in Impaired Animals, U.S. Patent No. 8,791,117, issued July 29, 2014.

 

130.     Michael Alan Black, Jonathan Cebon, Parry John Guilford, and Thomas John, Prognosis Prediction for Melanoma Cancer, U.S. Patent No. 8,822,149, issued September 2, 2014.

 

131.     Hjalmar Nekareda, Jan Frederichs, Bernard Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John Lindsay McCall, Y-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Melanoma Cancer, Japanese Patent No. 5632581, granted October 17, 2014.

 

132.     Leonid Grigorov, Methods and Devices for Programmable Delivery of Microdoses of Liquid Drugs, U.S. Patent No. 8,876,802, issued November 4, 2014.

 

133.     Samuel Falcone and Richard Berg, Carboxymethylcellulose Polyethylene Glycol Compositions for Medical Uses, Australian Patent No. 2008-330166, granted 8 January 2015.

 

134.     Noah Groth, Jan Warhuus, and Krassimir Anastassov Boyadjiev, Data Center Equipment Location and Monitoring System, U.S. Patent No. 8,994,532, issued March 31, 2015.

 

135.     Hjalmar Nekareda, Jan Frederichs, Bernard Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John Lindsay McCall, Y-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer, Korean Patent No. 10-1530689, granted 16 June 2015.

 

136.     Paul V. Lehmann, Multivalent Opsonophagocytic Assay Using Bead Array and Imaging, U.S. Patent No. 9,063,145, issued June 23, 2015.

 

137.     Michael John Bickerdike and Jian Guan, Cycllic-Glycyl-2-AllylProline Improves Cognitive Performance in Impaired Animals,  U.S. Patent No. 9,119,851, issued September 1, 2015.

 

138.     Margaret Brimble, Jian Guan, and Frank Sieg, Neuroprotective Bicyclic Compounds and Pharmaceutical Compositions Containing Them, European Patent No. EP 1 664,050 B1, granted 12 September 2015.

 

139.     Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose/Polyethylene Glycol Compositions for Medical Uses, U.S. Patent No. 9,161,987, issued October 20, 2015.

 

140.     Hjalmar Nekarda, Jan Friederichs, Bernard Holzmann, Robert Rosenberg, ANtony Edmund Reeve, Michael Alan Black, John Lindsay McCall, Yu-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer.  Korean Patent No. 10-1562644, Issued October 16, 2015.

 

141.     Lawrence Irwin Glass, Michael John Bickerdike, and Michael Frederich Snape, Treatment of Rett Symdrome Using Glycyl-L-2-Methylprolyl-L-Glutamic Acid, U.S. Patent No. 9,212,204, issued 15 December 2015.

 

142.     Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John Lindsay McCall, Yu-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer, Korean Patent No. 10-1579934, granted 26 December 2015.

 

143.     Angel DeCegama, Multilevel Video Compression, Decompression, and Display for 4k and 8K Applications, PCT Application No. PCT/US2015/040108, published 21 January 2016.

 

144.     Alexandr A. Golub, Olga O. Billaieva, Viacheslav v. Neshta, Antimicrobial Compositions, U.S. Patent No. 9,302,027, issued April 5, 2016.

 

145.     Parry John Guilford, Markers for Detection of Gastric Caner, U. S. Patent No. 9,310,370, issued 12 April 2016.

 

146.     Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose/Polyethylene Glycol Compositions for Medical Uses, U.S. Patent No. 9,345,809, issued 24 May 2016.

 

147.     Larry Glass, Michael John Bickerdike, and Michael Frederick Snape, Treatment of Autism Spectrum Disorders Using Glycyl-L-2-methylprolyl-L-Glutamic Acid, Australian Patent No. 2012209466, granted 16 June 2016.

 

148.     Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose/Polyethylene Glycol Compositions for Medical Uses, U.S. Patent No. 9,381,271, issued 5 July 2016.

 

149.     Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose/Polyethylene Glycol Compositions for Medical Uses, European Patent No. 2,211,907, granted 15 July 2016.

 

150.     Nikola Kirilov Kassabov, Matthias Futschik, Michael James Sullivan, and Anthony Edmund Reeve, Medical Decision Support Systems Utilizing Gene Expression and Clinical Information, European Patent No. 1,534,122, granted 20 July 2016.

 

151.     Hjalmar Nekarda, Jan Frederichs, Bernard Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John Lindsay McCall, Y-Hsin Lin, and Robert Craig Pollock, Prognosis Prediction for Colorectal Cancer.  Japanese Patent No. 6,058,780, granted 16 December 2016.

 

152.     Michael Alan Black, Jonathan Cebon, Parry John Guilford, and Thomas John, Devices and Methods for Prognosis Prediction for Melanoma Cancer, U.S. Patent No. 9,534,258, issued 3 January 2017.

 

153.     Sergey Saunin, Andrey V. Krayev, Vladimir V. Zhizhimontov, Vasily V. Gavrilyuk, Leonid N. Grigorov, Alexey V. Belyaev, Dmitry Evplov, Systems and Methods for Non-Destructive Surface Chemical Analysis of Samples, U.S. Patent No. 9,568,495, issued, 14 February 2017.

 

154.     Samuel Falcone, Compositions of Carboxymethylcellulose and Polyethylene Oxide Cross-Linked Using Polyhydroxyl Organic Anions.  U.S. Patent No. 9,636,434, issued 2 May 2017.

 

155.     Samuel J. Falcone and Richard A. Berg, Carboxymethylcellulose Polyethylene Glycol Compositions for Medical Uses, U.S. Patent No. 9,682,167, issued 20 June 2017.

 

156.     Parry John Guilford, Urine Gene Expression Ratios for Detection of Cancer, U.S. Patent No. 9,702,009, issued 11 July 2017.

 

157.     Timothy James Rossi, Method and System of Using Electromagnetism to Control Fertilizer Leaching, U.S. Patent No. 9,707,568, issued 18 July 2017.

 

158.     Lawrence Glass, Michael John Bickerdike, and Michael Frederick Snape, Treatment of Fragile X Syndrome Using Glycyl-L-2-Methylprolyl Glutamic Acid, U.S. Patent No. 9,708,366, issued 18 July 2017.

 

159.     Lawrence Irwin Glass, Michael John Bickerdike, and Michael Frederick Snape, Treatment of Autism Spectrum Disorders Using Glycyl-L-2-Methylprolyl Glutamic Acid, EP Patent No. 2,667,715, granted 19 July 2017.

 

160.     Nikola Kasabov, Adaptive Learning System and Method, EP Patent No. 1,287,488, granted 4 October 2017.

 

161.     Hjalmar Nekarda, Jan Frederichs, Bernard Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John Lindsay McCall, Y-Hsin Lin, and Robert Craig Pollock, Progonsis Prediction for Colorectal Cancer, Japanese Patent No. 6,218,141 , granted 6 October 2017.

 

162.     James P. Day, Interlocking Raft for Deepwater Culture Hydroponics, U.S. Patent No. 9,807,950, issued 7 November 2017.

 

163.     Parry John Guilford. Test Kits and Methods for Their Use in Detecting Expression Ratios of Genetic Markers, U.S. Patent No. 9,809,860, issued 7 November 2017.

 

164.     Samuel J. Falcone, Compositions of Carboxypolysaccharides and Polyalkylene Oxides Cross-Linked Using Polyhydroxyl Organic Anions, U.S. Patent No. 9,821,088, issued 21 November 2017.

 

165.     Lawrence Irwin Glass, Michael John Bickerdike, Michael Frederick Snape, and Patricia Perez DeCogram, Neuroprotective Bicyclic Compounds and Methods for Their Use in Treating Autism Spectrum Disorders and Neurodevelopmental Disorders.  U.S. Patent No. 9,867,823, issued 16 January 2018.

 

166.     Stephen Kilfeather, Alberto Taurozzi, Paul Lehmann, and Elaine Lee.  Immobilised-Bead Immunomultiplex Assay, U.S. Patent No. 9,945,786, issued 17 April 2018.

 

167.     Timothy James Rossi, Method and System of Using Electromagnetism to Control Fertilizer Leaching, EP Patent No. 3,079,789, granted 18 April 2018.

 

168.     Lawence Irwin Glass, Michael John Bickerdike, and Michael Frederick Snape, Treatment of Autism Spectrum Disorders Using Glycyl-2-Methylprolyl-L-Glutamic Acid, Japanese Patent No. 6,342,459, granted May 25, 2018.

 

169.     Parry John Guilford, Mark Dalphin, Laimonis Kavalieris, and Paul O’Sullivan, Polymerase Chain Reaction Test Kits for Detecting Markers for Bladder Cancer, U.S. Patent No. 9,982,305, Issued 29 May 2018.

 

170.     Sergey A. Saunin, Andrey V. Krayev, Vladimir V. Zhishimontov; Vasily V. Gravrilyuk, Lenoid N. Grigorov, Alexey V. Belyaev, and Dmitry Evplov, Systems and Devices for Non-Destructive Surface Chemical Analysis of Samples, U.S. Patent No. 9,989,566, Issued 5 June 2018.

 

171.     Lawrence Irwin Glass, Michael John Bickerdike, and Michael Frederick Snape, Treatment of Autism Spectrum Disorders Using Glycyl-2-Methylprolyl-L-Glutamic Acid, Japanese Patent No.  6,348,283, granted 8 June 2018.

 

172.     Parry John Guilford, Markers for Detection of Gastric Cancer, U.S. Patent No. 10,024,859, issued 17 July 2018.

 

173.     Samuel J. Falcone, Compositions of Carboxypolysaccharides and Polyethylene Oxides Cross-Linked Using Polyhydroxyl Organic Anions, U.S. Patent No. 10,052,408, issued 21 August 2018.

 

174.     John Fitzsimmons and Alexander Kuznetsov, Computer Assisted Egronomic Workstation Designs and Methods, U.S. Patent No. 10,078,096, Issued 18 September 2018.

 

175.     Stephen Kilfeather, Alberto Taurozzi, Paul Lehmann, and Elaine Lee, Immobilised-Bead Immunomultiplex Assay, EP Patent No. 2,536,818, Granted 3 October 2018.

 

176.     Timothy James Rossi, Method and System of Using Electromagnetism to Control Fertilizer Leaching, U.S. Patent No. 10,130,955, issued 20 November 2018.

 

177.     David Darling, James Miller Suttie, Mark Dalphin, Laimonis Kavalieris, Paul O’Sullivan, and Satish Kumar, Methods for Detecting Genetic and Phenotypic Biomarkers of Urothelial Carcinoma and Treatment Thereof.  U.S. Patent No. 10,131,955, issued 20 November 2018.

 

178.     James P. Day, Interlocking Raft Segment for Deepwater Culture Hydroponics, U.S. Patent No. 10,149,445, issued 11 December 2018.

 

179.     Parry John Guilford, Andrew John Holyoake, Markers for Detection of Gastric Cancer, U.S. Patent No. 10,179,935, issued 15 January 2019.

 

180.     Stephen Kilfeather, Alberto Taurozzi, Paul Lehmann, and Elaine Lee, Immobilised-Bead Multiplex Assay, GB Patent No. 2492268, granted 6 February 2019.

 

181.     Stefanie Kuerten and Paul Viktor Lehmann, CNS Antigen-Specific B Cell, T Cell and Antibody Assays and Their Uses in Diagnosis and Treatment of Multiple Sclerosis, EP Patent No. 2,707,013, granted 20 March 2019.

 

182.     Michael Alan Black, Parry John Guilford, Jonathan Cebon, Thomas John, Methods for Prognosis Prediction for Melanoma Cancer, U.S. Patent No. 10,266,902, issued 23 April 2019.

 

183.     Juan Nepomuc Walterspiel, Devices and Methods to Protect Neonates During Bed-Sharing and Co-Sleeping, U.S. Patent No. 10,362,882, issued 30 July 2019.

 

184.     Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann, Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, John Lindsay McCall, Yu-Hsin Lin, and Robert Craig Pollock, Methods for Treating Colorectal Cancer Using Prognostic Genetic Markers, U.S. Patent No. 10,422,005, issued 24 September 2019.

 

185.     Lawrence Irwin Glass, Michael John Bickerdike, Michael Fredrick Snape, and Patricia Perez DeCogram, Bicyclic Compounds and Methods for Their Use in Treating Autism Spectrum Disorders and Neurodevelopmental Disorders, Pat. No. JP 6,574,769, granted 23 August 2019.

 

186.     Lawrence Irwin Glass, Michael John Bickerdike, Michael Frederick Snape, Treatment of Autism Spectrum Disorders Using Glycyl-2-Methylprolyl-L-Glutamic Acid,  Pat. No. JP 6,640,275, granted 7 January 2020.

 

187.     Jaun Nepomuc Walterspiel, Devices and Methods to Protect Neonates During Bed-Sharing and Co-Sleeping, U.S. Patent No. 10,531,748, issued 14 January 2020.

 

188.     Lawrence Irwin Glass, Michael John Bickerdike, Michael Frederick Snape, and Patricia Perez De Cogram, Bicyclic Compounds and Their Use in Treating Autism Spectrum Disorders and Neurodevelopmental Disorders, U.S. Patent No. 10,548,892, issued 4 February 2020.

 

189.     Lawrence Irwin Glass, Michael John Bickerdike, Michael Frederick Snape, and Patricia Perez De Cogram, Bicyclic Compounds and Their Use in Treating Autism Spectrum Disorders and Neurodevelopmental Disorders, European Patent No. 3,024,463, granted 25 March 2020. 

 

190.     Parry John Guilford and Andrew John Holyoake, Treatment of Recurrent Gastric Cancer Identified Using Genetic Biomarkers,  U.S. Patent No. 10,689,707, issued 23 June 2020.

 

191.     Parry John Guilford, Test Kits and Methods for Their Use to Detect Genetic Markers for Urothelial Carcinoma of the Bladder and Treatment Thereof,  U.S. Patent No. 10,689,711, issued 23 June 2020.

 

 

TRADEMARK REGISTRATIONS

 

1.         U.S. Reg. No. 2,566,377, “ELANTEC,” Reg. Date: May 7, 2002.

 

2.         U.S. Reg. No. 3,182,039, “IMMUNOSCAN,” Reg. Date: December 5, 2006, Cellular Technology Limited. 

 

3.         U.S. Reg. No. 3,221,091. “SPOTMAP,”  Reg. Date: March 27, 2007, Cellular Technology Limited

 

4.         U.S. Reg. No. 3,438,787, “IMMUNOSPOT,” Reg. Date: June 3, 2008, Cellular Technology Ltd. 

 

5.         U.S. Reg. No. 3,450,024. ” PDS 400,” Reg. Date: June 17, 2008, Photomed Technologies, Inc. 

 

6.         U.S. Reg. No.3,468,580. “Photomed Ribbon” Misc. Design,” U.S. Reg. Date: July 15, 2008, Photomed Technologies, Inc.              

 

7.         U.S. Reg. No. 3,680,118, “SIMPL,” Reg. Date:  September 8, 2009, MSM Protein Technologies, Inc. 

 

8.         U.S. Reg. No. 3,532,352. “OASIS,” Reg. Date: November 11, 2008, Thomas Grebinski.

 

9.         U.S. Reg. No. 3,544,006, “BIOSPOT,” Reg. Date: December 9, 2008, Cellular Technology Ltd. 

 

10.       U.S. Reg. No. 3,602,913, “UVSPOT,” Reg. Date: April 7, 2009, Cellular Technology Ltd. 

 

11.       U.S. Reg. No. 3,612,813. “PHOTOMED TECHNOLOGIES (and Design),”  Reg. Date: April 28, 2009, Photomed Technologies, Inc.

 

12.       U.S. Reg. No. 3,753,512. “EPBMC,” Reg. Date: March 2, 2010, Cellular Technology Ltd.

 

13.       AU Reg. No. 1359886, LIPORALE, Reg. Date : 05 May 2010, Immune Solutions Ltd.

 

14.       CTM Reg. No. 008714181. CTL, Reg. Date: 2 June 2010, Cellular Technology Ltd.

 

15.       U.S. Reg. No. 3,823,344, “TB SCAN,” Reg. Date: July 30, 2010, CTL Analyzers LLC. 

16.       CTM Reg. No. 009080961, “LIPORALE,” Reg. Date: 27 September 2010, Immune Solutions Ltd.

 

17.       U.S. Reg. No. 3,855,285, “BIOSPOT,” Reg. Date: October 5, 2010, Cellular Technology Limited. 

 

18.       NZ Reg. No. 823728, “LIPORALE,” Reg. Date: 5 November 2010, Immune Solutions Ltd.

 

19.       U.S. Reg. No. 3,871,787, “UVSPOT,” Reg. Date November 9, 2010, Cellular Technology Limited.             

 

20.       CTM Reg. No. 006856769, “IMMUNOSPOT,” Reg. Date 11 November 2010, Cellular Technology Limited.

           

21.       CTM Reg. No. 009225178, “EPBMC,” Reg. Date 22 December 2010, Cellular Technology Ltd.               

 

22.       U.S. Reg. No. 3,909,607. “IMMUNOSPOT,” Reg. Date:            January 25, 2011, Cellular Technology Ltd:             

 

23.       U.S. Reg. No. 3,923,275. “LIPORALE,” Reg. Date:  February 22, 2011, Immune Solutions Limited:           

 

24.       U.S. Reg. No. 4,047,281. “MSM,” Reg. Date: November 1, 2011, MSM Protein Technologies, Inc. 

 

25.       U.S. Reg. No. 4,188,826, “CXBLADDER,” Reg. Date: 14 August 2012.

 

26.       U.S. Reg. No. 4,574,930, “APOLLO,” Reg. Date: July 29, 2014, Apollo Future Technology, Inc.

 

27.       U.S. Reg. No. 4,585,240, “MBDXA,” Reg. Date: August 12, 2014, MSACL, Inc.

 

28.       U.S. Reg. No. 4,608,560, “Miscellaneous Design (Shore, River and Mountains),” Reg. Date: 23 September 2014, Pacific Edge Limited.

 

29.       U.S. Reg. No. 4,662,781, “PACIFIC EDGE,” Reg. Date: 30 December 2014, Pacific Edge Limited.

 

30.       U.S. Reg. No. 4,717,259, “PACIFIC EDGE DIAGNOSTICS USA LTD plus Design,” Reg. Date: April 7, 2015, Pacific Edge Limited.

 

31.       U.S. Reg. No. 4,831,000, “FA-Q,” Reg. Date: October 13, 2015, Apollo Future Technologies, Inc.

32.       U.S. Reg. No. 4,836,584, “WACKY JACKY,” Reg. Date: October 20, 2015, Apollo Future Technologies, Inc.

 

33.       U.S. Reg. No. 4,836,592, “AMERICAN PIE,” Reg. Date: October 20, 2015, Apollo Future Technologies, Inc.

 

34.       U.S. Reg. No. 4,836,594, “FAUXSTESS CUPCAKES,” Reg. Date: October 20, 2015, Apollo Future Technologies, Inc.

 

35.       U.S. Reg. No. 4,836,599, “MISS SAMOA,” Reg. Date: October 20, 2015, Apollo Future Technologies, Inc.

 

36.       U.S. Registration No. 5,148,140, “SYNCRO-CLEANSE,” Reg. Date. February 21, 2016, Loprest Water Treatment Company.

 

37.       U.S. Reg. No. 4,973,720, “ERGONOMICS FIRST,” Reg. Date: June 7, 2016, Ergonomics First, Inc.

 

38.       U.S. Reg. No. 5,975,051, “HIPTORQUE,” Reg. Date: June 7, 2016, Ergonomics First, Inc.

 

39.       U.S. Reg. No. 5,089,887, “LOPREST,” Reg. Date: November 29, 2016, Loprest Water Treatment Company.

 

40.       U.S. Reg. No. 5,360,832, “SPOT STAT,” Reg. date:  December 19, 2017, Cellular Technology Limited.

 

41.       U.S. Reg. No. 5,510,715, “Miscellaneous Drawing (“Stickman”), Reg. Date: July 10, 2018, Thomas Dawson.

 

42.       U. S. Reg. No. 5,529,111, “TUBENMANN,” Reg. Date: July 31, 2018, Thomas Dawson.

 

43.       U.S. Reg. No. 5,787,070, “TVA,” Reg. Date: June 25, 2019, Cellular Technology Limited.

 

LEGAL PUBLICATIONS

 

87.       Borson, D.B.   Finding Another On-Ramp to 101, Illumina Inc., Sequenom, Inc. v.

Ariosa, AIPLA Patent Law Committee Newsletter, 22-28 21 October 2020.

 

86.       Borson, D.B.   Patent Eligibility:  Another Diagnostic On Ramp to Highway 35

U.S.C. 101: CardioNet v. Braemar” AIPLA Patent Law Committee, Newsletter, 14-21, 21 October 2020.

 

85.       Borson, D.B.   Patent Eligibility:  Another Diagnostic On Ramp to Highway 35

U.S.C. 101: CardioNet v. Braemar” AIPLA BIOTECH_BUZZ, Patent Law Committee, Patent Eligibility Subcommittee, October 2020.

 

84.       Borson, D.B.   Obviousness-Type Double Patenting Is Not So Obvious: Immunex

v. Sandoz, AIPLA BIOTECH_BUZZ, Patent Law Committee, Biologics Subcommittee October 2020.

 

83.       Borson, D.B.   Patent Eligibility:  Another Diagnostic On Ramp to Highway 35

U.S.C. 101: CardioNet v. BraemarNew Matter, 45(3):15-20 (Fall 2020), Intellectual Property Law Section, California Lawyers Association.

 

82.       Borson, D.B.   Obviousness-Type Double Patenting Is Not So Obvious: Immunex

v. Sandoz, New Matter 45(3):24-27 (Fall 2020), Intellectual Property Law Section, California Lawyers Association.

 

81.       Borson, D.B.   Patent Claims “Consisting Essentially Of,” New Matter, 45(2):

16-18, 31 (Summer 2020), Intellectual Property Law Section, California Lawyers Association.

 

80.       Borson, D.B.   Finding Another On-Ramp to 101, Illumina Inc., Sequenom, Inc. v.

Ariosa, New Matter, 45(2):5-9, (Summer 2020), Intellectual Property Law Section, California Lawyers Association.

                                                                                                            

79.       Borson, D.B.   Comprising at Least One of Consisting of: Markush Practice in

2020, New Matter, 45(1):19-21, 35 (Spring 2020), Intellectual Property Law Section, California Lawyers Association.

 

78.       Borson, D.B.   Broad Institute CRISPR:  EPO Patent RevocationNew Matter,

45(1):15-35 (Spring 2020), Intellectual Property Law Section, California Lawyers Association.

 

77.       Borson, D.B.   “Wherein” the Money: Limiting, Inherent, or Aspirational?  New

Matter 44(4):8-10, 18 (Winter 2019), Intellectual Property Law Section, California Lawyers Association.

 

76.       Borson, D.B. & Report of the Legislation Interest Group to the Executive

   Mark Leonard          Committee: S.2082, the STRONGER Patents Act of 2019, (12

November 2019), Intellectual Property Law Section,

California Lawyers Association.

 

75.       Borson, D.D.   Rule Changes Affecting Trademark Practitioners, New Matter

44(3):40 (Fall 2019), Intellectual Property Law Section, California Lawyers Association.

 

74.       Borson, D.B.   Bypassing Highway [35 U.S.C. Section] 101: Congress in Search

of an Alternative Route to Patent Eligibility, New Matter, 44(3): 17-23 (Fall 2019), Intellectual Property Law Section, California Lawyers Association.

 

73.       Borson, D.B.   Bypassing Highway [35 U.S.C. Section] 101: Congress in Search

of an Alternative Route to Patent Eligibility, Biotech_Buzz 12 August 2019, Diagnostics and Gene Patenting Subcommittee, American Intellectual Property Law Association.

 

72.       Borson, D.B. &Report of the Legislation Interest Group to the Executive

   Mark Leonard          Committee: Patent Eligibility, Intellectual Property Law Section,

California Lawyers Association (13 July 2019).

 

71.       Borson, D.B. & Report of the Legislation Interest Group to the Executive

   Mark Leonard          Committee: Music Modernization Act, Intellectual Property Law

Section, California Lawyers Association (23 March 2019).

           

70.       Borson, D.B.   Athena Diagnostics, Inc., v. Mayo Collaborative Services, LLC,

Slip. Op. 2-17-2509 (Federal Circuit, 6 February 2019).

Biotech_Buzz (March 2019), Case Law Reviews Subcommittee,

Biotechnology Committee, American Intellectual Property Law

Association.

 

69.       Borson, D.B.   Keep Your Genes Fresh with a CRISPR: Report on Interference

                                    between University of California v. Broad Institute, Inc.New

                                    Matter, 43(4):8-12, 35, (Winter 2018).  Intellecutal Property Law

                                    Section, California Lawyers Association.

 

68.       Borson, D.B.   University of California v. Broad Institute, Inc. Biotech_Buzz,

                                    (October 2018). Case Law Reviews Subcommittee, Biotechnology

                                    Committee, American Intellectual Property Law Association.

 

67.       Borson, D.B.   Artificial Intelligence: S.2217, H.R. 4625 New Matter 43(3):12-17,

                                    (Fall 2018), Intellectual Property Law Section, California Lawyers

                                    Association.

 

66.       Borson, D.B.   Highway [35. U.S.C. Section 101]: Finding the On Ramp,

                                    New Matter, 43(2):11-14 (Summer 2018), Intellectual Property

                                    Law Section, California Lawyers Association.

 

65.       Borson, D.B.   Commentary: Do the Proposed Rulemaking Claim Construction

                                    Standard Changes Go Far Enough, New Matter, 43(2):29-30

                                    (Summer 2018), Intellectual Property Law Section, California

                                    Lawyers Association.

 

64.       Borson, D.B.   Vanda Pharmaceuticals, Inc. v. West-Ward Pharmaceuticals

                                    International, West-Ward Pharmaceuticals CorpBiotech­_Buzz,

                                    Case Law Reviews Subcommittee, Biotechnology Committee,

                                    AIPLA (13 April 2018).

 

 

63.       Borson, D.B. & S. 2217 and H.R. 4625 the “Fundamentally Understanding The

   Mark Leonard          Usability and Realistic Evolution of Artificial Intelligence Act of

                                    2017” or the “FUTURE of Artificial Intelligence Act of 2017,”

                                    and H.R. 4829, the “Artificial Intelligence Job Opportunities and

                                    Background Summary Act of 2018 or the ‘AI JOBS Act of 2018,”  

                                    Report of the Legislation Interest Group, Intellectual Property Law

                                    Section, State Bar of California (March 2018).

 

62.       Borson, D.B.   Patent Eligibility, Catch Me if You Can, MCLE Self-Study Article,

                                    Intellectual Property Law Section, California Lawyers Association

                                    New Matter 43(1):10-14, 55 (Spring 2018).

 

61.       Borson, D.B.   Berkheimer v. HP, Biotech Buzz Case Law Review Subcommittee,                                   AIPLA (February 2018).

 

60.       Borson, D.B.   Genzyme Corp. Sanofi-Aventis U.S., LLC v. Dr. Reddy’s

                                    Laboratories Ltd, Dr. Reddy’s Laboratories, Inc. and Teva

                                    Pharmaceuticals, Biotech Buzz Case Law Review Subcommittee,

                                    Biotechnology Committee, AIPLA (January 2018).

 

59.       Borson, D.B.   Supreme Court Decisions: Sandoz Inc. v. Amgen, Inc. et al.,

                                    New Matter 42(3): 23-26, 43, Intellectual Property Law Section,

                                    State Bar of California (Fall 2017).

 

58.       Borson, D.B. &   Report of the Legislation Interest Group to the Intellectual     

   Mark Leonard          Property Law Section Executive Committee: S. 974 and H.R. 2212 The “Creating and Restoring Equal Access To Equivalent Samples” Act (“CREATES” Act) or “CREATES Act of 2017” 29 July 2017, State Bar of California.           

 

57.       Borson, D.B. &   Federal Legislation Update:  Report of the Legislation Interest

   Mark Leonard          Group to the Intellectual Property Law Section Executive

                                    Committee (21 July 2017).

 

56.       Borson, D.B.   Short Comment on Section 101; New Matter 42(1):13-14 (Spring

                                    2017)

 

55.       Borson, D.B.   In re van Os et al., Biotech Buzz, AIPLA Case Comment

                                    Subcommittee (January 2017).

 

54.       Borson, D.B. & Federal Legislation Update: new initiatives before the U.S.

            Mark Leonard House   of Representatives, Report of the Legislation Interest Group to the Intellectual Property Law Section Executive Committee Report on 12 January 2017, State Bar of California.

 

53.       Borson, D.B.   Recent Federal Legislation, Trans Pacific Partnership Agreement

                                    and Protect Trade Secrets Act, New Matter 41(2):28-33 (2016),

                                    State Bar of California Intellectual Property Law Section.

 

52.       Borson, D.B.   Genetic Technologies Limited v. Merial L.L.C. Bristol-Meyers           

                                    Squibb Company, Biotech Buzz, Case Law Review Subcommittee,                                   AIPLA, April 2016.

 

51.       Borson, D.B. &  Report of the Legislation Interest Group to the Intellectual     

            Mark Leonard             Property Law Section on the Trans Pacific Partnership                

                                    Agreement and America Invents Act, State Bar of California,  

                                    19 March 2016.

 

50.       Borson, D.B. &  Report of the Legislation Interest Group to the Intellectual     

            Mark Leonard             Property Law  Section on the Trans Pacific Partnership                

                                    Agreement, State Bar of California, 12 January 2016.

 

49.       Borson, D.B. &  Report of the Legislation Interest Group to the Intellectual     

            Mark Leonard             Property Law  Section, State Bar of California, 2 November 2015.   

           

48.       Borson, D.B.   Comments on July 2015 Guidance on Eligible Subject Matter, 26

                                    October 2015, http://www.uspto.gov/patent/laws-and-regulations/comments-public/comments-july-2015-update-subject-matter-eligibility.

 

47.       Borson, D.B.   The Medicines Company v. Hospira, Inc. Biotech Buzz, Case Law

                                    Review Subcommittee, AIPLA, August 21, 2015.

 

46.       Borson, D.B.   Legislation Update, New Matter 40(1):23-30 (Spring 2015).

            Leonard, M.

 

45.       Borson, D.B.   Legislation Update, New Matter 39(4):19-20 (Winter 2014).

            Leonard, M.

 

44.       Borson, D.B.   Case Summary of AbbVie v. Janssen, Biotech Buzz Case Law

                                    Review Subcommittee, AIPLA (16 July 2014).

 

43.       Borson, D.B.   Legislation Interest Group Report: Extract, New Matter 39(1):61-

            M. Leonard     62 (2014).

           

42.       Schultz, A. &  Report from the International Interest Group on Changes in

            Borson, D.B,   Australian Practice,  New Matter 39(1):47-48 (2014).

                       

41.       Borson, D.B.   Comments on New USPTO Guidance for Examination of

                                    Applications Including Laws of Nature, submitted to USPTO (29

                                    April 2014).

 

40.       Borson, D.B.   Senju v. Apotex, Biotech Buzz, AIPLA Biotech Committee,  

                                    (April 18, 2014).

 

39.       Borson, D. B.  Methods Claims Must Recite Specific Steps Needed to Achieve

                                    Results, Smartgene v. Advanced Biological Labs.,

                                    Biotech Buzz, AIPLA Diagnostics & Gene Patenting

                                    Subcommittee, February 24, 2014.

 

38.       Craig, A.G &  Addressing Unfair Litigation Practices in Patent Law, New Matter

            Borson, D.B.   38(4):19-23 (Winter 2013)

 

37.       Borson, D.B.   Sunovion v. Teva and Dr. Reddy’s, Biotech Buzz, Case Law

                                    Review Subcommittee, AIPLA, November 2013

 

36.       Borson, D.B.   Biogen v. GSK,  Biotech Buzz, Case Law Review Subcommittee,  AIPLA. (April 16, 2013).

 

35.       Borson, D.B.   Annual Report of the Patent Public Advisory Committee, USPTO

            et al.                November 2. 2012.

 

34.       Borson, D.B.   Avoiding Disputes, Keep the Litigants Out of It. Business Law Corporate Counsel Section, Contra Costa Lawyer, August 1, 2012.

 

33.       Borson, D.B.   The Leahy-Smith America Invents Act of 2011: Section 3 of the

            D. Eastham     AIA.     New Matter, 37(1):11-21 (2012).

 

32.       Matteo D.C.    Annual Report of the Patent Public Advisory Committee, USPTO

             et al.               November 4, 2011)

 

31.       Borson, D.B.   The Leahy-Smith America Invents Act of 2011: An Introduction.

            D. Eastham     New Matter, 36(4): 5-24 (2011).

 

30.       Matteo, D.C.   Annual Report of the Patent Public Advisory Committee,

             et al.              November 1, 2010.

29.       Borson, D.B.   Proposed Legislation on Patent Reform and IP, New Matter 34(2):160-161 (2009).

 

28.       Borson, D.B.   Legislation Committee Report of May 4, 2009, New Matter 34(2): 60-66 (2009).

 

27.       Friedman         Report of the Delegation of IP Section of the State Bar of

            et al.                California to Washington D.C., April 6, 2009, New Matter 34(2):48-52 (2009).

 

26.       Borson, D.B.   Legislation Committee Report, New Matter 33(2):50-51 (2008).

 

25.       Grunebach      A Town Focused on Change; IP Law Section’s 2008 Delegation to

            et al.,               DC, New Matter 33(2):40-45 (2008).

                       

24.       Borson, D.B.   Assisting with U.S. Patent Prosecution and Preserving U.S. Patent Rights, In: U.S. Patent Practice for Paralegals: HalfMoon LLC. pp:4-1 to 4-83 (2008).

23.       Borson, D.B.   Note from the Legislation Committee, New Matter 32(4):4 (2007).

 

22.       Borson, D.B.   Report of the Legislation Committee: USPTO Final Rules on

                                    Claims and Continuations. New Matter 32(2):44-57 (2007).

 

21.       Mendoza         Annual D.C. Trip Plays a Key Role in Maintaining Strong Federal

            et al.                Relationships, New Matter 32(2)34-39 (2007).

 

20.       Borson, D.B.   KSR v. Teleflex, Inc.: The Supreme Court Reviews Obviousness. J. Patent and Trademark Office Society 89(7):523-544 (2007).

 

19.       Borson, D.B.   KSR v. Teleflex, Inc.: The Supreme Court Reviews ObviousnessNew Matter 32(1):11-39 (2007).

 

18.       Borson, D.B.   LabCorp v. Metabolite: Legal and Scientific Terminology: An Example of Poor CorrelationNew Matter, 31(3):31-43 (2006).

 

17.       Borson, D.B.   Changes to Practice for Continuing Applications Requests for

           et al.                 Continued Examination Practice and Applications Containing Patentably Indistinct Claims, Ad-Hoc Commission of California Attorneys, Comments submitted to USPTO May 3, 2006.

 

16.       Borson, D.B.   Proposed Rules for Patent Practice: Continuations and ClaimsNew Matter 31(2): 16-20 (2006).

 

15.       Borson, D.B.   Comments on Proposed Rules (37 C.F.R. Part 11), Ad-Hoc

  et al.,                         Committee of Registered Patent Attorneys, Submitted to USPTO June 10, 2004.

 

14.       Borson, D.B.   Intellectual Property Strategies in the Life Sciences: Introduction to Biotechnology PatentsIBC Life Sciences, Inc. (November 2003).

 

13.       Borson, D.B.   Current Status of U.S. Patent Law.  In: Intellectual Property Practice for ParalegalsHalf Moon Seminars, LLC. Eau Claire, WI, 1I-1- I50 (2003).

 

12.       Borson, D.B    Doctrine of Equivalents in Light of the Supreme Court’s Decision

                                    in Festo:  Law and Equity in Intellectual Property.         New Matter 27(2/3): 9-10, 36-43, (2002).

 

11.       Borson, D.B.   Intellectual Property Protection in High Technology Industries:

           &S.R.Meyer:   Trade Secrets, Patents, and Ethics.  State Bar of California Convention, September 7, 2001.

 

10.       Borson, D.B.   State Immunity from Federal Patent and Trademark Laws, Part II.      

                                    New Matter, 26(1-2):5-10 (2001).

 

9.         Borson, D.B.   Protecting Inventions in Combinatorial Chemistry

                                    Cambridge Healthtech Institute Symposium on Exploiting

                                    Molecular Diversity Refining Small Molecule Libraries (February

                                    12-14, 2001).

 

8.         Borson, D.B.   State Immunity from Federal Patent and Trademark Laws, Part I.       

                                    New Matter 25(2):3-6 (2000).

 

7.         Borson, D.B.   Patenting Inventions in Combinatorial Chemistry, Journal of Molecular Graphics and Modeling 18(1):63-71 (2000).

 

6.         Borson, D.B.   Overview of Intellectual Property Protection.  In: Intellectual

                                    Property Practice for Paralegals.  Half Moon Seminars, LLC

                                    Eau Claire, WI, pp:I1-I4 (1998).

 

5.         Borson, D.B.   International Patent Practice.  In: Intellectual Property Practice

                                    for Paralegals Half Moon Seminars, LLC. Eau Claire, WI, V1 –

                                    V40 (1998).

 

4.         Borson, D.B.   The Human Genome Project: Patenting Human Genes and

                                    Biotechnology. Is the Human Genome Patentable Subject Matter?

                                    IDEA, Journal of Law and Technology, 35(4):461-496 (1995).

 

3.         Borson, D.B.  Health Care: The Big Picture.  USF Forum (Oct 24 1994).

 

2.         Borson, D.B.   Extended Parentship Act.  Model Statute In:  Adrienne D. Davis,

                                    Symposium: Surrogacy Legislation in California; USF Law Rev.

                                    28(3): 582 - 588 (Spring 1994).

 

1.         Borson, D.B., Reform of Compassionate Use of Therapeutic Drugs.  In: Daily

           Wong, M., &    Recorder (San Francisco) (May 5 1993).

            Carriere, D.

 

 

INSTRUCTIONAL ACTIVITIES

 

Law and Intellectual Property

 

2018-               Guest Lecturer on Entrepreneurship and Intellectual Property, St. Mary’s College of California, Undergraduate and Graduate Entrepreneurship Programs.

 

2016                Understanding Patents in Mass Spectrometry. Develop and deliver workshop to members of the Mass Spectrometry Applications for the Clinical Laboratory (MSACL) annual Convention.

 

2014                Update on Patents and Trademarks, Staff Research Conference, Pacific Edge Limited.

 

2014                Mass Spectrometry Applications in the Life Sciences: develop and deliver lectures on commercialization and intellectual property.

 

2013-14           Society for Brain Mapping and Therapeutics: develop and deliver lectures on commercialization and intellectual property.

 

2009-2015       Contra Costa County Bar Association, Business Law Corporate Counsel Section: develop, organize and deliver lectures in business and IP law.

 

2011-2014       Australian Biotechnology Organization (AusBiotech): develop and

                        present lectures on commercialization and international IP law.

 

2010-2015       Golden Gate University School of Law

                        Adjunct Professor of Law, Course Director and lecturer:  Biotechnology

                        Law, Patent Law

 

2009-2013       New Zealand Biotechnology Organization (NZBIO): develop and

                        present lectures on International IP law and commercialization.

 

2006-               Borson Law Group, PC: develop and present workshops and lectures on

                        intellectual property protection, scientific processes, commercialization,

                        and defense for clients.

 

2001-               State Bar of California

Intellectual Property Section Representative to the Conference of

Delegates of California Bar Associations: Coordinate and implement

            activities of the Council of State Bar Sections. Develop and implement strategies for statewide continuing legal education.

                        Lectures for State Bar Annual Meeting, 2001-2008

                        Lectures for State Bar IP Section Annual Institute

                        Lecture for State Bar of California:  In House Litigation Symposium 2004.

                        Chair, Planning Committee for U.S.P.T.O. Symposia, 2003, 2005

Lecturer, State Bar Annual Meeting, 2003-2006: Overview of IP and

            Ethics in IP Practice.

Lecturer, Intellectual Property Institute, 2002 - 2006. Delivered lectures on

            Claim Drafting, Law and Equity in IP, Ethics in IP Practice and IP

            overview

Member, Planning Committee for the Business Law/Intellectual Property

            Law Section Third Annual Joint Meeting, La Costa Resort, 2002.

Prepared and delivered lectures on Patent Claiming Strategies, Business

            Aspects of IP law, Legal Ethics in Intellectual Property Practice,

            Doctrine of Equivalents and Law & Equity

                        Member, Planning Committee for Copyright Office Comes to California.

                        Author, articles relating to intellectual property

 

2002 -  2011    BioScience Forum, non-profit, educational corporation for Life Science professionals: Founder and President: Formerly Northern California Pharmaceutical Discussion Group.  Organize and moderate lectures, panel discussions and symposia relating to life sciences, regulatory affairs and legal affairs for scientists, entrepreneurs and professional personnel. Prepare and present lectures on IP law to life scientists.

 

1997 - 2006    Fliesler Meyer LLP (Formerly Fliesler, Dubb, Meyer & Lovejoy LLP)

                        Develop and implement strategies for teaching attorneys intellectual

                                    property law

                        Prepare and deliver IP lectures to Attorneys and Staff.

                        Mentor attorneys in IP practice.

                        Develop and present lectures relating to Patent Office procedures and case                            law

Prepare and deliver lectures to universities, businesses and professional

            organizations relating to discovery inventions, intellectual

            property, life sciences, chemistry and biotechnology

 

1997 - 2002     Northern California Pharmaceutical Discussion Group

                        Non-profit educational organization (became BioScience Forum).

Organize and moderate lectures in Life Sciences for business and

            professional personnel. Prepare and deliver lectures relating to

            intellectual property law.

 

LEGAL PRESENTATIONS

 

Graduate Entrepreneurship and Intellectual Property, St. Mary’s College of California Guest Lecture.  17 March 2020.

 

Undergraduate Entrepreneurship and Intellectual Property, St. Mary’s College of California Guest

Lecture.  25 November 2019.

 

Graduate Entrepreneurship and Intellectual Property, St. Mary’s College of California Guest Lecture.  13 May 2019.

 

Entrepreneurship and Intellectual Property, St. Mary’s College of California Guest

Lecture.  21 March 2019.

 

Entrepreneurship and Intellectual Property, St. Mary’s College of California Guest

Lecture. 26 November 2018.

 

Patent Eligible Subject Matter, Obviousness, and Obviousness-Type Double Patenting

Contra Costa County Bar Association, Intellectual Property Law Section Conference. April 17, 2018.

 

Two Entrepreneurs Walk Into a Bar to Mull Over Purchase Offer, Contra Costa County Bar Association CLE Spectacular, November 18, 2016.

 

Understanding Patents in Mass Spectrometry, Workshop presented to the Annual Convention of the Mass Spectrometry Applications for Clinical Laboratories (MSACL), Palm Springs, CA February 23, 2016.

 

Two Entrepreneurs Walk Out of a Bar: Panel Discussion on the Legal Issues Faced by Businesses. Contra Costa County Bar Association CLE Spectacular, November 20, 2015.

 

Two Entrepreneurs Walk Out of a Bar: Panel Discussion on the Legal Issues Faced by Businesses.  John F. Kennedy University Entrepreneurs October 22, 2015.

 

Patent Law of the United States: Course Director and Lecturer:  Golden Gate

University School of Law, (August – November 2015).

 

Creating Win-Win Scenarios Between Australia and China: Lecture and Panel:

AusbioTech Invest Conference, Melbourne Australia (2-3 December 2014).

Patent Law of the United StatesCourse Director and Lecturer:  Golden Gate

University School of Law, (August – November 2014).

 

Two Entrepreneurs Walk into a Bar, Presentation for the John F. Kennedy University

Innovation Cluster, (June 11, 2014).

 

Recent Foreign Patent Legislation and USPTO Rulemaking, Patent Interest Group

Teleconference, IP Law Section, State Bar of California, (April 10, 2014).

 

Translational Medicine, Education, Policy, Commercial and IPIssues, Keynote Speaker:

Society for Brain Mapping and Therapeutics, 11th Annual Convention, Sydney,

Australia, (18 March 2014).

 

Commercialization and Protection of Intellectual Assets in Application to Mass

Spectrometry,Plenary Lecturer: Mass Spectrometry Applications in Clinical

Laboratory, Annual Convention, (March 2, 2014).

 

Multijurisdictional Ethics: Review of California and USPTO Rules of

Professional Responsibility;  State Bar of California Intellectual Property Law

Institute, (November 8, 2013).

 

Patent Law of the United States. Course Director and Lecturer:  Golden Gate

University School of Law, (August – November 2013).

 

Bringing Inventions to the Wider World: Protection Strategies and Commercialization; Invited Speaker, Society for Brain Mapping and Therapeutics 10th World Conference on Brian Mapping (May 14, 2013).

 

 

Biotechnology Law, Course Director and LecturerGolden Gate University School

of Law, (January – May 2013).

 

Using Intangible Assets in Starting and Running a BusinessBusiness Law Corporate

Counsel Section, Contra Costa County Bar Association, (April 24, 2013).

 

Patent Law of the United States. Course Director and Lecturer: Golden Gate

University School of Law, (August – November 2012).

 

Getting Started in Business: How to Advise Start-Up Enterprises.  With Peter Sproul,

Contra Costa County Bar Association Business Law Corporate Counsel Section,

(July 18, 2012).

 

New United States Patent Laws and Implications for New Zealand Biotechnology,

Speaker, Organizer and Chair, NZBIO Convention Auckland, New Zealand, (March

26, 2012): 

 

How to Fire your Bad Clients and Keep the Good Ones. Business Law Corporate Counsel Section, Contra Costa County Bar Association CLE Spectacular, (November 18, 2011).

 

Intellectual Property: An Element of Success of a Technology Company’s Life Cycle, Australian Biotechnology Organization Conference, Adelaide, Australia, (October 2011).

 

Workshops on the America Invents Act of 2011, International and             Commercialization Strategies, Organizer and Speaker, NZBIO, Auckland & Dunedin New Zealand, (October 2011).        

 

The Leahy-Smith America Invents Act of 2011. Intellectual Property Law Section Teleseminar, State Bar of California:

 

Copyright Threats to Companies With Web Designs, Business Law Corporate Counsel/Intellectual Property Section presentation with Stuart West, Contra Costa County Bar Association, (June 16, 2011).

 

Tips on Starting an IP Firm, State Bar of California IP Section teleseminar, (May 24, 2011).

 

Biotechnology LawCourse Director and Lecturer: Golden Gate University School of Law, (January – May 2011).

 

What Every Business Attorney Needs to Know About Intangible Assets. Business Law Corporate Counsel Section, Contra Costa County Bar Association, (April 20, 2011).

 

Commercialization and Intellectual Property Strategies, NZBIO             Conference, Auckland, New Zealand, (March 23, 2011).

 

Workshops on International Intellectual Property and Commercialization     Strategies, Organizer and Speaker: University of Otago and Otago Innovation Ltd, Dunedin, New Zealand, (March 2011).

 

Update on Federal Legislation and USPTO Rulemaking. State Bar of California Teleseminar, Cyberlaw program, (January 29, 2011).

 

Patenting and Patent Law from Legal and Technical Viewpoints, State Bar of California Teleseminar, Cyberlaw program, (January 2011).

 

Creating a World-Wide Intellectual Property Strategy, NZBIO Annual Convention, Auckland New Zealand, (March 18, 2010).

 

Section 101, Utility and Patentable Subject Matter in the Discovery Arts,    USPTO Biotechnology, Chemical and Pharmaceutical Partnership Meeting.  (September 8, 2010).

 

International Intellectual Property Law, Acquisition, Exploitation and Enforcement:

State Bar of California Section Education Institute, (January 17, 2009).

 

California and Federal Ethics in Intellectual Property Law, State Bar of California

Annual Meeting, (September 26, 2008).

Assisting with U.S. Paten Prosecution, In: U.S. Patent Practice for Paralegals: HalfMoon

LLC. (June 26, 2008).

 

Intellectual Property Basics for Non-Specialists State Bar of California Section

Education Institute, (January 18, 2008).

 

New Patent Legislation and PTO Rule Changes, State Bar of California Intellectual

Property Institute, (November 10, 2007).

 

Ethics Issues in Intellectual Property Practice, State Bar of California Annual Meeting, (September 28, 2007).

 

Discovery Inventions: UCSF Entrepreneur Camp, (July 30, 2007).

 

Law of Obviousness in Light of KSR, Pfizer and Takeda: Possible Patent Strategies,

Silicon Valley Intellectual Property Law Association,  (September 13, 2007).

 

New Legislation and Case Law:  State Bar of California Intellectual Property Annual

Institute, (November 2007).

 

International Law Weekend West.   Santa Clara University School of Law, Santa Clara,

California,       (February 2-3, 2007).

 

Patent Practice Nuts and Bolds of Intellectual Property, State Bar of California

Intellectual Property Section Institute, (November 2006).

 

Continuing Applications, Fliesler Meyer LLP Training Meeting, November 1, 2006.

 

Ethics and Multijurisdictional Intellectual Property Practice, State Bar of California

Annual Meeting, (October 5, 2006).

 

Patent Practice: Current Strategies and Future Trends, San Diego Intellectual Property

Law Association, (June 22, 2006).

 

International Intellectual Property Protection: Comparisons of U.S. and Foreign

Practice Issues for the General Practitioner, State Bar of California Annual Meeting,

(October 2006).

 

Technology Transfer Systems and Intellectual Property ProtectionOsaka University

Institute of Scientific and Industrial Research, Osaka, Japan.

 

Litigation and Arbitration: Fliesler Meyer LLP, (2006).

 

Careers in Science: IP Management and Technology Transfer, Stanford         University, (November 7, 2005).

Resolution of Patentability Disputes in EuropeUCLA Symposium on International IP Practice, (September 16, 2005).

 

Multijurisdictional Ethics: California and Federal Law: State Bar of California Annual

Meeting, (September 11, 2005).

 

Patent Strategies for Follow-On ProductsIBC’s 3d Annual International Conference

on Global Follow-On Biologics, Reston, VA, (December 6-7 2004).

 

Trust and Ethics in Intellectual Property Practice.   State Bar of California Intellectual

Property Section Annual Institute, (November 6, 2004).

 

Patents on Discoveries in the Life Sciences, State Bar of California Intellectual

Property Section Annual Institute, (November 5, 2004).

 

Intellectual Property Rights Abroad: How to Obtain, Maintain and Defend Them, State

Bar of California Annual Meeting, (October 9, 2004).

 

Ethics in IP and Corporate MattersState Bar of California Intellectual Property

Section Annual Institute, (October 8, 2004).

Technology Transfer in the Life Sciences, DNA Bridges Symposium, (September 23,

2004).

 

Intellectual Property Strategies for Biotechnology Inventions,  Haas Intellectual Property Workshop,  Haas School of Business, UC Berkeley, (June 11, 2004).

 

Intellectual Property Ethical Issues for In-House CounselState Bar of California: In

House Litigation Conference, (May 21, 2004).

 

IP Protection & Provisional Pate4nts for Bio-related Inventions, UCSF Entrepreneurs’

Discussion Group, (November 19, 2003).

 

Post-Festo Update Law and Equity in Intellectual Property, State Bar of California

Annual Intellectual Property Institute, (November 8, 2003).

 

Intellectual Property Strategies for Live Science Companies: Introduction to

Biotechnology Patents, Course Director and Lecturer: IBC Life Sciences. (November

3-4, 2003).

 

Discovery Inventions: Scientific and Legal Issues in Life Sciences Patents, Fliesler Meyer LLP (formerly Fliesler Dubb Meyer & Lovejoy LLP), 2003).

 

Whose Invention is it?  University of California, San Francisco, Innovation

Accelerator. (2003).

 

Ethics in Intellectual Property Law practice.  Organizer and Moderator, State Bar of

California 76th Annual Meeting, (September 4, 2003).

 

Current Status of U.S. Patent Law. Half Moon Seminars, LLC, Eau Claire, WI, (June

17, 2003).

 

Protection of Discovery Inventions in the Life Sciences, BioScience Forum, Milbrae, California (June 18, 2003).

 

IP Strategies and Implications in the Life Sciences, In: Symposium: Defining and

Defending Intellectual Property Rights in Biotechnology.J. Thomas McCarthy Institute

of IP and Technology Law   University of San Francisco School of Law, (March 22,

2003).

 

Intellectual Property Issues in Medical Devices.  Drug Information Agency, (February

24-26, 2003).

 

Doctrine of Equivalents in Light of Recent Case Law Including Festo v. SMC Corp.: Law

and Equity in Intellectual Property. State Bar of California Fall Intellectual Property

Institute, (November 9, 2002).

Ethics and Intellectual Property Practice. State Bar of California Fall Intellectual

Property Institute, (November 6-8, 2002).

 

Patent Claiming and Prosecution Strategies. Patent Standing Committee, State Bar of

California Intellectual Property Institute, (November 8, 2002).

 

Ethical Considerations in IP Practice, FDML Staff Conference,             (October 21, 2002).

 

Doctrine of Equivalents in Light of Festo. v. SMC, J&J v. RES and Symbol Tech. v.

Lemelson: Law and Equity in Intellectual Property, Intellectual Property Seminar

Series, Fliesler, Dubb, Meyer & Lovejoy, LLP, (June 27, 2002).

 

Ethics and Intellectual Property PracticeState Bar of California 3rd Annual Spring Meeting, Business Law. Intellectual Property Joint Meeting, State Bar of California, (May 19, 2002).

 

European Patents, Intellectual Property Rights, Trade Secrets, Trademarks and Branding

IssuesIn: Winning Strategies for Biomedical Companies in the              European Union,

World Trade Organization of the Bay Area (2002).

 

Protecting Intellectual Property in High Technology: Trade Secrets, Patents and Ethics,

State Bar of California Annual Meeting, (September 7, 2001).

 

Preparing a Patent Application for Issuance, Half-Moon Seminars for Paralegals, (June

13, 2001).

 

Doctrine of Equivalents in Light of Festo v. Shoketsu Kinzoku Kogyo Kabushiki Co. and

SMC Pneumatics, Inc.  Fliesler Dubb Meyer & Lovejoy LLP Attorneys’ Meeting,

(March 1, 2001).

 

Patent Law, Biotechnology and DNAUniversity of San Francisco School of Law:

Intellectual Property Law Association, (February 22, 2001).

 

Current Issues in Biotechnology Patents: Hastings School of Law: Intellectual

Property Organization, (February 21, 2001).

 

Protecting Inventions in Combinatorial Chemistry, Keynote Address:  Cambridge

Healthtech Conference: Eighth Annual Exploiting Molecular DiversityRefining

Small Molecule Libraries, (February 13, 2001).

 

Filing Patent Applications. Fliesler Dubb Meyer & Lovejoy LLP Staff Conference,

(January 24, 2001).

                       

Patenting Biotechnological and Pharmaceutical Inventions, Northern California Pharmaceutical Discussion Group, (December 13, 2000).

State Immunity from Federal Patent and Trademark LawsCalifornia State Bar Association, IP Law Section, Patent Standing Committee teleconference, (2000).

 

State Immunity from Federal Patent and Trademark Laws: Fliesler, Dubb, Meyer &

Lovejoy Continuing Legal Education Program, (June 23, 1999).

 

Overview of Intellectual Property International Patent PracticeHalf-Moon Seminars,

Inc.     

                                   

Changes to United States Patent Rules.   Fliesler, Dubb, Meyer & Lovejoy Continuing

Legal Education Program, (1997).

 

Uses of DNA Technology in Forensic Sciences University of San Francisco Continuing

Legal Education Program, (1994).

 

 

SYMPOSIA ORGANIZED

 

USPTO Comes to California, Intellectual Property Law Section of the State Bar of California, Los Angeles and San Francisco, California (May 12, 14, 2010).

 

United States Patent and Trademark Office TC 1600 West Coast Road Show 2010, Organizer and Moderator, BioScience Forum, Millbrae,             California, (February 24, 2010).

 

United States Patent and Trademark Office TC 1600 West Coast Road Show 2008,

Organizer and Moderator, BioScience Forum, Millbrae, California (November 12,

2008).

 

United States Patent and Trademark Office TC 1600 West Coast Road Show 2007,

Organizer and Moderator, BioScience Forum, Millbrae, California (October 31, 2007).

 

United States Patent and Trademark Office TC 1600 West Coast Road Show 2005, Organizer and Moderator, BioScience Forum, Millbrae, California (October 18, 2005).

 

Pain: Mechanisms and Therapeutics, Organizer and Moderator, BioScience Forum,

Millbrae, California, (November 19, 2004).

 

Hot Topics in Biotechnology Patent Law: USPTO Technology Center 1600, BioScience

Forum, Millbrae California, (September 9, 2004).

 

Application of Biomarkers to the Drug Discovery and Development Process, Organizer

and Moderator, BioScience Forum, Millbrae, California (June 25, 2004).

 

 

Clinical Trials Symposium: The Impact of Regulatory Changes on Strategic Planning for

Clinical Trials, BioScience Forum, San Mateo, (8 January 2003).

 

Current Topics in Protein and Drug Binding: Conceptual, Clinical and Regulatory Issues, Organizer and Moderator, BioScience Forum, Millbrae, California (May 9, 2002).

 

United States Patent and Trademark Office Symposium: Hot Topics in Biotechnology &

Software Patents and New Legislation, Organizer and Moderator, Northern California

Pharmaceutical Discussion Group, Millbrae, California (September 20, 2000).

 

 

EMPLOYMENT IN SCIENCE

           

1976 - 1992     University of California San Francisco, Department of Physiology: Physiology and Pharmacology for Schools of Medicine, Pharmacy, Dentistry and Physical Therapy:

Developer and lecturer, cardiovascular, pulmonary, gastrointestinal and    

            renal physiology

Developer and lecturer: National Board Review Program in Physiology

            and Biochemistry, School of Dentistry,

            Combined       lecture/laboratory program in Physiology: Physical Therapy          

            Program

Designed courses, prepared course materials, prepared and delivered

            lectures, wrote and evaluated examinations, supervised student

            laboratories, individual tutorials

                        Cardiovascular Research Institute University of California San

                                    Francisco:

Prepared and delivered numerous lectures relating to scientific research at

            University, National and International meetings

Taught and supervised staff and post-doctoral fellows relating to scientific

            investigations in neuroscience, physiology, molecular biology,

            biochemistry and pharmacology. 

Supervised post-doctoral fellows in scientific writing for publications

                        Mentored post-doctoral fellows in drafting research grants

1986-1992       Adjunct Lecturer, Department of Physiology, UCSF

1986-1992       Assistant Research Physiologist, Cardiovascular Research Institute,

                        UCSF

1983-1986       Post Doctoral Fellow, Cardiovascular Research Institute, UCSF

 

 

EMPLOYMENT IN OTHER DISCIPLINES

 

1969 - 1977     Federal Aviation Administration Certified Flight Instructor, Airplane and Instrument; Ground Instructor:  Airplane, Private, Commercial, Instrument and Multi-engine pilot ratings.  President and Chief Pilot, Buchanan Flying Club

 

1960-               Concert Flutist

                        Performances of Baroque, Classical, Romantic, Modern, and Avant Garde music, orchestral, chamber works, and solo performances.  President, Bay Flute Club, President, Amphion Music Club, President, Contra Costa Performing Arts Society, member Etude Club, Senza Rito, Music Section of University of California, Berkeley.

                                   

1960 - 1968     Flute Instructor

                        Instructed private students and master classes,

 

 

HONORS AND AWARDS

 

2018                Lifetime Achievement Award, Marquis Who’s Who.

2018                Intellectual Property Law Achievement Award, Marquis Who’s Who.

2018                President of the Board of Directors, Contra Costa Performing Arts

                        Society.

2015-               Member of the Board of Directors, Contra Costa Performing Arts

                        Society

2014-2018       President, Amphion Music Club.

2014-               Member of the Board of Directors, Amphion Music Club

2014                Member, Committee on Professional Responsibility and Conduct,

                        State Bar of California

2010-2015       Adjunct Professor of Law, Golden Gate University School of Law.

2014-2016       Treasurer, Business Law Corporate Counsel Section, Contra Costa

                        County Bar Association.

2014-               Co-Chair, AIPLA Patent Law Committee, Subcommittee on Patent

                        Policy.

2010-2013       Chair, Business Law Corporate Counsel Section, Contra Costa County

                        Bar Association.

2009-2012       Member, Patent Public Advisory Committee, USPTO

2009-2011       Co-Chair, AIPLA Subcommittee on Section 101, Patent Committee

2011-2013       Co-Chair, AIPLA Patent Law Subcommittee on Patentability.

2009-2011       Delegate from IP Section of California State Bar to the Conference of

                                    California Bar Associations

2007-2009       Delegate from IP Section of California State Bar: Conference of Delegates

                                    of California Bar Associations

2006-               Chair, Intellectual Property Law Section Legislation Interest Group

2004-2006       Member, Board of Governor’s Task Force on Sections, State Bar of

                                    California.

2004-2008       Advisor, Intellectual Property Law Section, State Bar of California

2006-               Member, IP Law Section and International Law Section, State Bar of  

                                    California

2004-2006       Chair, Intellectual Property Section Commission on Proposed USPTO

                                    Rules of Professional Responsibility.

2003-2005       Co-Vice Chair (2003), Co-Chair (2004-2005)

                                    Council of State Bar of California Sections

2002-2009       Founder and President, BioScience Forum, non-profit life sciences

                                    educational corporation

2002-2004       IP Section Representative: Council of Sections: State Bar of California.

2001-2004       Member: Executive Committee: State Bar of California Intellectual

                                    Property Section

2001-               Member: Intellectual Property Advisory Committee: USF School of

                                    Law

2000- 2002      Chair, Northern California Pharmaceutical Discussion Group

1999 -              Member, Patent Standing Committee, State Bar of California

1999-2000       Chair-Elect, Northern California Pharmaceutical Discussion Group

1998-2000       Advisory Board, Board of Directors: Northern California

                                    Pharmaceutical Discussion Group.

1994-1996       Board of Directors, Balboa Terrace Homes Association

1991                Member, Special Review Committee, National Institute of Health:

                                    National Heart, Lung, and Blood Center of Research Program

1990 -              Biography listed in:

                                    Who’s Who in the World                                          

                                    Who’s Who in America

                                    Who’s Who of American Attorneys

                                    Who’s Who in Science and Technology

                                    Who’s Who in Education

                                    Who’s Who in the West

 

1989-1994       NIH Program Project Grant: HL 24136 Project D7:

                                    Modulation of Airways by Neutral Endopeptidase

 

1988-1991       Cystic Fibrosis Research Development Program Grant: RO 149-1

                                    Neuropeptide Release from Airways

1989 to 1992   Editorial Board, American Journal of Physiology: Lung Cellular and

                                    Molecular Physiology

1987-1992       Principle Investigator, NIH First Independent Research Service and

                                    Transition Award:  HL-38947, Role of Enkephalinase in

                                    Regulating Airways.

1987                Co-inventor: Therapeutic Use of Enkephalinase

                                                U.S. Patent No. 5,262,178 issued 1993

                                                U.S. Patent No. 5,403,585 issued 1995.

1986-1987       UCSF Academic Senate Committee on Research Grant:

                                    Regulation of Release of Airway Glycocalyx by Proteinases

1985-1986       UCSF Research Education and Allocation Committee Grant:

                                    Effects of Peptides and Proteinases on Airway Secretion.

1984-1989       NIH Program Project Grant: HL 24136: Project D7:

                                    Regulation of Airway Secretion.

1984-1986       American Lung Association of California Grant:

                                    Roles of Inflammatory Peptides in Regulating Mucus Secretion

1984 - 1986     Parker B. Francis Research Fellowship

1984                Cystic Fibrosis Research Fellowship

1983 - 1984     United States Public Health Service Postdoctoral Fellowship

1976 - 1982     United States Public Health Service Predoctoral Traineeship

                                   

 

SCIENTIFIC EXPERIENCE

 

1990 -  1992    GENENTECH, INC., South San Francisco, Department of Cellular                               

                        Genetics: Visiting Scientist.

Original Scientific Research 

Designed and carried out studies in biochemistry, molecular biology, gene expression, cell culture, cellular transformation & mutagenesis of a mammalian cell surface enzyme with therapeutic utility.

 

1986 -  1992   UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

            Cardiovascular Research InstituteAssistant Research Physiologist

Original Scientific Research:

Ran biomedical research laboratory, Trained Staff and supervised post-doctoral

            fellows.

Physiology and Pharmacology, Designed and carried out physiological and

            pharmacological studies on glycoprotein secretion, regulation of muscle

            action, reflexes interaction of different branches of the nervous system, 

            hormonal regulation in vivo and in vitro

Biochemistry: Designed and carried out biochemical studies of peptide

            degradation, enzyme purification, neurotransmitter release, and macro

            molecular secretion. 

Molecular Biology and Genetics:  Designed and carried out molecular biological

            studies on gene transcription, translation, and product translation of

            endogeneous and exogeneous genes in tissues and cell culture.

            Wrote and administered research grants

Authored over 80 publications in mammalian physiology, biochemistry, and

            molecular biology relating to neural and humoral regulation of

            mammalian organ systems

Inventor          Therapeutic Use of Enkephalinase. Two Issued Patents

Teacher  Physiology, cell biology, biochemistry, molecular biology, scientific

            research methods, scientific writing

Service to Scientific Community:  Reviewed manuscripts and grants.  Presented       

            lectures and seminars, and chaired scientific meetings.

 

1986 - 1992     UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

Department of PhysiologyAdjunct Lecturer

            Lectures and Laboratories: Physiology, pharmacology and biochemistry

            for students in Medical, Pharmacy, Dentistry and Physical Therapy

            programs.

 

1983 - 1986     UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

            Cardiovascular Research Institute, Postdoctoral Fellow

            Original Scientific Research: 

                        Neural and humoral regulation of the respiratory system

 

1976-1983       UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

            Department of Phisiology, Graduate Student

            Ph.D. Dissertation:  Neural Regulation of Secretion from Tracheal Submucosal

            Glands (1983)

 

SELECTED INVITED SCIENTIFIC LECTURES

 

1983                National Institutes of Health, Clinical Staff Conference

                        Neurohumoral Regulation of Airway Secretion

1983                University of Hawaii, Clinical Physiology Conference

                        Inflammatory Regulation of Airway Secretion

1984, 1986      Vicks Division of Research: Conference on Respitory Secretions

                        Neurohumoral Regulation of Airway Secretion

1988                Transatlantic Airways Conference, Lucerne, Switzerland

                        Roles of Neutral Endopeptidase in Regulating Airways

1988                University of California, San Francisco: Department of Physiology

                        Roles of Peptides and Proteinases in Regulating Airway Functions

1988                International Conference on Rhinitis and Asthma, Smygehamn, Sweden

                        Airway Secretions.

1988                Third Annual Conference on Clinical Immunology, San Francisco

                        Neuropeptides and the Lung: Animal Models and Human Disease

1988                UCSF Quality Assurance and Clinical Conference; Adult Allergy Faculty Practice; Neuropeptides and Lung Reactions.

1989                Temple University Pulmonary Division; Conference on Proteases in Disease:  Role of Neutral Endopeptidase in   Airways

1989                University of Pennsylvania Department of Pediatrics and Physiology

Roles of Neutral Endopeptidase in Regulating Peptide-Induced Phenomena

1989                Temple University Department of Physiology

                        Role of Neutral Endopeptidase in Regulating Peptide-Induced Responses

1990                XIII International Congress of Asthmology

                        Neutral Endopeptidase as a Possible Anti-inflammatory Drug

1990                Dokkyo University

                        Roles, Regulation, and Therapeutic Potential of Neutral Endopeptidase

1990                Women’s University of Tokyo Roles, Regulation, and Therapeutic Potential of Neutral Endopeptidase

1991                Stanford University School of Medicine; Cystic Fibrosis Research Group

                        Roles and Regulation of Neutral Endopeptidase

 

 

SELECTED SCIENTIFIC PUBLICATIONS

 

Peer-Reviewed Articles

 

1.         Borson DB, Chinn RA, Davis B, Nadel JA.  Adrenergic and cholinergic nerves mediate fluid secretion from tracheal glands of ferretsJ Appl Physiol  49:1027-1031, 1980.

2.         Borson DB, Charlin M, Gold BD, Nadel JA.  Neural regulation of 35SO4-macromolecule secretion from tracheal glands of ferretsJ Appl Physiol 57:457-466, 1984.

 

3.         Gashi AA, Borson DB, Finkbeiner WE, Nadel JA, Basbaum CB.  Neuropeptides degranulate serous cells of ferret tracheal glands.  Am J Physiol 251(Cell Physiol 20):C223-C229, 1986.

 

4.         Borson DB, Corrales R, Varsano S, Gold M, Viro N, Caughey G, Ramachandran J, Nadel JA.  Enkephalinase inhibitors potentiate substance P-induced secretion of 35SO4-macromolecules from ferret tracheaExp Lung Res 12:21-36, 1987.

 

5.         Caughey GH, Viro NF, Ramachandran J, Lazarus SC, Borson DB, Nadel JA.  Dog mastocytoma tryptase: affinity purification, characterization and amino-terminal sequence.  Arch Biochem Biophys 258:555-563, 1987.

 

6.         Sekizawa K, Tamaoki J, Nadel JA, Borson DB.  Enkephalinase inhibitor potentiates substance P- and electrically induced contraction in ferret tracheaJ Appl Physiol 63:1401-1405, 1987.

 

7.         Varsano S, Basbaum CB, Forsberg LS, Borson DB, Caughey G, Nadel JA.  Dog tracheal epithelial cells in culture synthesize sulfated macromolecular glycoconjugates and release them from the cell surface upon exposure to extracellular proteinases.  Exp Lung Res 13:157-183, 1987.

 

8.         Dusser DJ, Nadel JA, Sekizawa K, Graf PD, Borson DB.  Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret tracheaJ Pharm Exp Ther 244:531-536, 1988.

 

9.         Sheppard D, Thompson JE, Scypinski L, Dusser D, Nadel JA, Borson DB.  Toluene diisocyanate increases airway responsiveness to substance P and decreases airway enkephalinase. J Clin Invest 81:1111-1115, 1988.

 

10.       Dusser DJ, Umeno E, Graf PD, Borson DB, Nadel JA.  Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivoJ Appl Physiol. 65:2585-2591, 1988.

 

11.       Kohrogi H, Graf PD, Sekizawa K, Borson DB, Nadel JA.  Neutral endopeptidase inhibitors potentiate substance P- and capsaicin-induced cough in awake guinea pigs.  J Clin Invest 82:2063-2068, 1988.

           

12.       Djokic TD, Sekizawa K, Borson DB, Nadel JA.  Neutral endopeptidase inhibitors potentiate substance P-induced contraction in gut smooth muscleAm J Physiol 256:G39-G41, 1989.

 

13.       Djokic TD, Nadel JA, Dusser DJ, Sekizawa K, Graf PD, Borson DB.  Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchiJ Pharmacol Exp Ther 248:7-11, 1989.

 

14.       Borson DB, Brokaw JJ, Sekizawa K, McDonald DM, Nadel JA.  Neutral endopeptidase and neurogenic inflammation in rats with respiratory infectionsJ Appl Physiol. 66:2653-2658, 1989.

 

15.       Kohrogi H, Nadel JA, Malfroy B, Gorman C, Bridenbaugh B, Patton JS, Borson DB.  Recombinant human enkephalinase (neutral endopeptidase) prevents cough induced by tachykinins in awake guinea pigsJ Clin Invest 84:781-786, 1989.

 

16.       Dusser DJ, Djokic TD, Borson DB, Nadel JA.  Cigarette smoke induces bronchoconstrictor hyperresponsiviness to substance P and inactivates airway neutral endopeptidase in the guinea pigJ Clin Invest, 84:900-906, 1989.

 

17.       Rubinstein I, Iwamoto I, Ueki IF, Borson DB, Nadel JA.  Recombinant neutral endopeptidase attenuates substance P-induced plasma extravasation in the guinea pig skin. Int Arch Allergy and Appl  Immunol. 91:232-238, 1990.

 

18.       Borson DB, Gruenert DC.  Glucocorticoids increase expression of neutral endopeptidase in transformed human tracheal epithelial cellsAm. J. Physiol. 260 ( Lung Cell. Mol. Physiol. 4):L83-L89, 1991.

 

19.       Katayama M, Nadel, J.A, Bunnett NW, DiMaria, G.U, Haxhiu, M.A., Borson DB.  Catabolism of calcitonin gene-related peptide by neutral endopeptidasePeptides 12:563-567, 1991.

 

20.       DiMaria GU, Katayama M, Borson DB, and Nadel JA.  Neutral endopeptidase modulates endothelin-1-induced airway smooth muscle contraction in guinea pig

            Regul. Peptides 39:137-145, 1992.      

 

 

Review Articles, Books, and Book Chapters

 

21.       Borson, DB. Neural regulation of secretion from tracheal submucosal glands

            Ph.D. Dissertation.  University of California, San Francisco, CA (1982).

 

22.       Nadel JA, Borson DB, Basbaum DB, Widdicombe JH.  Techniques for studying airway mucus secretion, ion transport and water movement.  In Techniques in the Life Sciences.  Techniques in Respiratory Physiology - Part I.  Otis AB, ed.  Elsevier Scientific Publishers Ireland Ltd., County Clare, Ireland, pp:1-35, 1984.

 

23.       Nadel JA, Borson DB.  Secretion and ion transport in airways during inflammationBiorheology 24:541-549, 1987.

 

24.       Nadel JA, Borson DB.  Modulation of neuropeptide actions by enkephalinaseIn Pharmacology. Rand MJ, Raper C, eds.  Elsevier Science Publishers B.V., pp: 425-439, 1987.

 

25.       Nadel JA, Borson DB.  Modulation of tachykinins and bradykinin by enkephalinase.  In Mechanisms in Asthma:  Pharmacology, Physiology, and Management.  Armour CL, Black JL, eds. Alan R. Liss, Inc. New York, pp:123-130, 1987.

 

26.       Borson DB, Gashi AA, Nadel JA.  Methods for studying secretion from airways.  In: Methods in Mucology.  Braga PC, Allegra L, eds. Raven Press, New York City, pp: 303-334, 1988.

 

27.       Borson DB, Nadel JA.  Regulation of airway secretions.  In  Workshop on Rhinitis and Asthma; Similarities and Differences.  Mygind N, Pipkorn U, Dahl R, eds. Munksgaard, Copehnagen, Denmark, Chapter 6, pp:76-99, 1990.

 

28.       Borson DB.  Roles of neutral endopeptidase in airways. Am. J. Physiol. 260 (Lung Cellular and Molecular Physiol. 4:L212-L225, 1991.

 

29.       Borson, DB, Nadel, JA.  Neutral Endopeptidase as a Possible Therapeutic Drug.  In: Advances in Asthmology 1990: Proceedings of the XIII International Congress of Asthmology, held in Maebashi, Japan.  S. Kobayashi, J.A. Bellanti, Eds. Elsevier, Amsterdam. pp: 373 - 381, 1991.

 

30.       Borson, DB.  Possible Roles of Peptides and Peptidases in AsthmaAmerican College of Chest Physicians, Pulmonary and Critical Care Update: 8(8):1-12, 1992.

 

Abstracts

 

31.       Gamsu G, Borson B, Webb WR, Nadel JA.  Structure: function correlation in tracheal stenosisAm Rev Respir Dis 115:328, 1977.

 

32.       Borson B, Chinn R, Davis B, Nadel J.  Electrical stimulation of cholinergic nerves to submucosal glands in ferret trachea in vitroPhysiologist 22:12, 1979.

 

33.       Borson DB, Nadel J.  Mucous secretory response of canine tracheal pouch.  Fed Proc 38:1330, 1979.

 

34.       Borson DB, Nadel JA.  Adrenergic neurotransmission to tracheal submucosal glands of ferretsClin Res 29:98A, 1981.

 

35.       Borson DB, Nadel JA.  Cholinergic nerves inhibit adrenergic neurotransmission to tracheal submucosal glands of ferretsFed Proc 40:254, 1981.

 

36.       Borson DB, Charlin M, Gold BD, Nadel JA.  Nonadrenergic noncholinergic nerves mediate secretion of macromolecules by tracheal glands of ferretsFed Proc 41:1754, 1982.

 

37.       Borson DB, Caughey G, Lazarus SC, Gold WM, Nadel JA.  Neutral proteases of canine mastocytoma cellsFed Proc 44:1276, 1985.

 

38.       Borson DB, Corrales RJ, Viro N, Nadel JA.  Substance P (SP) regulation of 35SO4 macromolecule secretion from ferret tracheaAm Rev Respir Dis 131:A27, 1985.

 

39.       Borson DB, Gold M, Varsano S, Caughey G, Ramachandran J, Nadel JA.  Enkephalinase inhibitors potentiate tachykinin-induced release of 35SO4-labeled macromolecules from ferret tracheaFed Proc 45:626, 1986.

 

40.       Borson DB, Malfroy B, Gold M, Ramachandran J, Nadel JA.  Tachykinins inhibit enkephalinase activity from tracheas and lungs of ferretsPhysiologist 29:174, 1986.

 

41.       Forsberg LS, Varsano S, Borson DB, Basbaum CB, Nadel JA.  Keratinase-sensitive cell surface glycans are synthesized by cultured tracheal epithelial cellsFed Proc 45:1904, 1986.

 

42.       Sekizawa K, Tamaoki J, Nadel JA, Borson DB.  Enkephalinase inhibitor (leucine-thiorphan) potentiates mammalian tachykinin-induced contraction in ferret tracheaFed Proc 46:650, 1987.

 

43.       Sheppard D, Thompson JE, Scypinski L, Dusser D, Nadel JA, Borson DB.  Toluene diisocyanate increases airway responsiveness to substance P and decreases airway enkephalinasePhysiologist  30:196, 1987.

 

44.       Borson DB, Brokaw J, Sekizawa K, McDonald D, Nadel JA.  Viral infection increases permeability response to substance P (SP) by decreasing tracheal neutral endopeptidase (NEP).  FASEB J. 2:A1382, 1988.

 

45.       Borson DB, Brokaw J, Sekizawa K, McDonald D, Nadel JA.  Viral infection increases tracheal permeability response to substance P (SP) in rats by decreasing neutral endopeptidase (NEP).  J Cell Biochem [Suppl] 12B:295, 1988.

 

46.       Nadel JA, Djokic TD, Djokic LT, Borson DB.  Neutral endopeptidase inhibitor potentiates neurotensin-induced contraction in guinea pig bronchiFASEB J. 2:A1383, 1988.

 

47.       Kohrogi H, Nadel JA, Malfroy B, Gorman C, Bridenbaugh B, Patton JS, Borson DB.  Recombinant enkephalinase inhibits substance P- and capsaicin-induced cough in awake guinea pigsAm Rev Respir Dis 139:A133, 1989.

 

48.       Borson DB, Jew S, Gruenert DC.  Glucocorticoids increase expression of neutral endopeptidase in transformed human tracheal epithelial cellsPhysiologist 32:226, 1989.

 

49.       Katayama M, Bunnett NW, Ueki IF, Nadel JA, Borson DB.  Recombinant human neutral endopeptidase (NEP) cleaves calcitonin gene-related peptide (CGRP)FASEB J. 4:A998, 1990.

           

50.       DiMaria GU, Katayama M, Graf PD, Borson DB, Nadel JA.  Neutral endopeptidase modulates endothelin-induced contraction of guinea pig tracheaPharm. Res. 22 (Suppl2):170, 1990.

 

51.       Borson DB, Gruenert DC.  Cystic Fibrosis cells in culture express neutral endopeptidase (NEP, enkephalinase)Pediatric Pulmonology (Suppl. 5):250, 1990.

                                                                                                                                               

52.       Borson DB, Katayama M.  Calcitonin gene-related peptide inhibits cleavage of substance P by recombinant human neutral endopeptidaseFASEB J.5:A863, 1991.

 

53.       Katayama M, Nadel JA, Borson DB.  Recombinant human neutral endopeptidase (NEP) cleaves human endothelin (ET1). FASEB J. 5:A863, 1991.

 

54.       Borson DB, Gies D, and C. Gorman.  Transmembrane domain is necessary for           expression of functional human neutral endopeptidaseJ. Cell. Biol. 115:61A,          1991.